犬 Babesia gibsoni 感染症の治療と予防に関する研究
全文
(2) nj Babesia gibsoni ŒƐǤ*ƭǧ%ʏ(ʋ=ǶȄ. 2018 IJ. ĨʍċĖċĖʒɸâǐÔĖǶȄǾ ʮĮijǛǖċĖʯ. Ǫƪ £Ʌ.
(3) nj Babesia gibsoni ŒƐǤ*ƭǧ%ʏ(ʋ=ǶȄ. Ǫƪ £Ʌ.
(4) ǭƛ. ĵɞ ………………………………………………………………………...……………….1. Ȋ 1 Ȉ nj B. gibsoni ŒƐǤƭǧ(
(5) =¦ǗʅVteZǧƯ*ƭǧÐƏ%ė½Ō *ɗ …………………………………………………………………………………..…..4 1 ȣɐ …………………………..…………………………………...…..…...…….……..4 2 ƊŶ
(6) :.ŸƯ ………………………………………………………………………..5 3 ȝƏ …………………………………………………………………….…...….…........7 4 Ȫġ ………………………………...…………………………………..……...……….9 5 Ĥť …………………………………………………………………………….……..13. ȊʵȈ nj B. gibsoni ŒƐǤ*Àǩʏƞ(ʋ=ǶȄ ………………….…………..21 ȣɐ ………………………………………………………………..……………….……..21 Ȋ 1 ȑ ¦ǗʅVteZǧƯ%O}^sFU*ț4â@ƭǧƯ*nj B.. gibsoni ŒƐǤÀǩʏƞÐƏ*Ɩɒ …………………………………………………..22 1 ĵɞ ……………………………………………………………………….......……22 2 ƊŶ
(7) :.ŸƯ ……………………………………………………………………22 3 ȝƏ …………………………………………………………………………………24 4 Ȫġ …………………………………………………………………………………25 Ȋ 2 ȑ DVWsFU%dMUSFO}*nj B. gibsoni ŒƐǤÀǩʏƞÐƏ* Ɩɒ ………………..………………..……………….…………………………….……..26 1 ĵɞ …………………………………………………………………………...……26 2 ƊŶ
(8) :.ŸƯ ……………………………………………………………………26 3 ȝƏ ………………………...………………………………………………………27 4 Ȫġ ………………………………………………...………………………………28 Ĥť ……………………………………………………………………………….……….31.
(9) ȊʶȈ nj B. gibsoni ŒƐǤƲɅü(
(10) =nj* B. gibsoni ʤŌŒƐǍƮ .…..38 1 ȣɐ ………………………………………………...………………………………38 2 ƊŶ
(11) :.ŸƯ …………………………………………………………………...38 3 ȝƏ ………………...……………………………………………………………....40 4 Ȫġ ……………………………………………………...………………………....41 5 Ĥť ……………...…………………………………………………………...…….44. Ȣť ……………………………………………………………………………..…….…..48 ɟɮ ………………………………………………………………………………..….…..51 ŵǏ …………………………………………………………………………………...…..53.
(12) ǜɛ ɍ. CBC. ½ɄǓɑȎ. RBC. ɥɄǓ. Hb. pwPkǀĶ. PCV. ɄǓĝȃ. PLT. ɄĤƍ. T.P. Ȣ]iOǀĶ. AST. aspartate aminotransferase ³. ALT. alanine aminotransferase ³. ALP. alkaline phosphatase ³. T. Cho. ȢRWa~³. T. Bil. Ȣk}~kǀĶ. BUN. ɄĦȘȆȘǀĶ. Cre. OD_fǀĶ. Na. ec}GuǀĶ. K. K}GuǀĶ. Cl. ĄȘǀĶ. Glu. Ʉȕ³. Alb. D~nt³. Ca. K~UGuǀĶ. CRP. C ÝňŌ]iOɤ. IMHA. »ǟûŌƼɄŌɢɄ. EDTA. I_VDtóʂʃ.
(13) ĵ ɞ. njhqUDǤ+nj*s^fĒŌǢŎ*' $ƃ7ʄɊ'7** !$=[27, 34]njhqUDǤ*ǣÚ§%#ÚɃ* Babesia canisB. gibsoniB. vogeli. B. conradae
(14) :. B. rossi Ǵ;>#
(15) <>3$({`i*ùAņ (ÓȔÓƌDm}Kƌ×DVDŻƉAç5ƌDVD3$ijȒ÷'ǩǕɚ 6;># =[1, 7, 9, 13, 16, 36] ǚǫ(+ B. canis % B. gibsoni AÚõ%= āé1%B&$=ˀ7ˁŻƉ(
(16) =njhqUD+LJĮüÿ*ƫȥ(+ B.. canis 8 B. vogeli Ǖō=7**ċĊŴ+ B. gibsoni $=[25, 46, 52] nj(
(17) = B. gibsoni ŒƐǤʮnj B. gibsoni ŒƐǤ%=ʯ$+ƼɄŌ ɢɄ8ǩLJȳȵʬǠ'&ʄȓ'ǤǍA¢ %ĊƢ(Ⱥ=%7= ƭǧ(+VteZDY_ycʮVteZʯŞÚɃɂ%#ǚ $ijªǗ># =[10, 57, 60]VteZ+ŗù$+ljlo|XsǤ( Ģ#Śɚł;># =nj B. gibsoni ŒƐǤ(Ģ#+Śɚ># ' VteZ+nj(Ģ#ưģʁ¥*Ǹȝ8ǡǥ%%7(ĤȲÂɄ% Ȼëǫ' ͨǗAƅ#
(18) <ĤÑNJȸĴĜ(%. #ɾş( ɂÌ$=[7, 10, 57, 60]. ɰIJͨǗôʀAǭǫ%#ŞÚɃƱŌAŦ!Şȿɂ*ĊÌ©ǗǧƯāé > >;*Şȿɂ*ŞÚɃƱŌ+9=8 $ôŃ(ƀʊ =6 [65]Ň7ȸĴĜ*ďőAł;>=ƭǧƯ$+' *ŀŞs|}Dɂ$ =DchRADVWsFU%©ǗƭǧocR~nj B. gibsoni Œ ƐǤ(ƅÐ%āé>[8] *ŀ*ocR~(:=ƭǧ(7Àǩ ɚ6;> [32, 60];(+ B. gibsoni * CYTɿ¡Ĕ*Ƙ'ĈǞNj(Dc hRȫŌA
(19) =Ɋ'ȅDŽĈǞ$= M121I ĈǞƒ*Âǒž; %' [22, 41, 42]*ŀDchR%oPDf~*âÌ*ƅÐŌāé> 8+<Àǩɚ6;>[23] ù¿(
(20) =nj B. gibsoni ŒƐǤ*ƭǧ(+ċĊŴ*ȸĴĜVteZAªǗ. 1.
(21) # =VteZ+Ƴĉ$+ 35 mg/kgȌȬ¿ŝAØǎ7+ 2 ôŝ ># =[7, 45, 57, 69] ŸŻƉù¿$+VteZ*ŝʅŝƯÜ. ͨǗ*ʋ¯(! #*Ƭ;*āé(Ā"[50]ƓƭǫƭǧƯ$+' 7** ė½$ʈƆǫ'ǰʋ»ǟł;>=ŸƯ%#[7]VteZ*¦ǗʅɈŴôŝ Ư%# 2 mg/kgʗŻ 3 ôŝƯʮ¦ǗʅVteZǧƯ%=ʯij ƁÜ# = *¦ǗʅVteZǧƯ*ͨǗ8ôŃ3$*ɄƶŌǍ* ĈÒ'&+§Ȗǫ(ɗ>#
(22) ;ȸĴǫ(+ƓŤ(Ā" ƭǧƯ('. #. + ' $3Ȋ 1 Ȉ$+nj B. gibsoni ŒƐǤƭǧ(¦ǗʅVteZǧ ƯAɅ ôŃ3$*ÑåAɏƎ#ƭǧÐƏ%ė½ŌAɗ nj B. gibsoni ŒƐǤ+ÀǩĊ ǢŎ$=%7:Ǵ;># =[4, 10, 73, 74] *ǔǙ%#ǒƀǁ$+ '=ƭǧ$7Ɠƭǫ( B. gibsoni ŒƐAĘ ½(§ĉ/Ūʓ$' ;$=[27, 37]nj B. gibsoni ŒƐǤ(
(23) =Àǩ+ żƭǨǍœ*ŀ(Mx}D%'<ǰʋ»ǟ(:. #ÀŒƐ=%'%. 7ȸĴǤǍÀLj=%$ƀ(ğǕɃɄǤ*ąŏA¢ %7=[7, 27]M x}D$=%+ãƀ(Àǩ*}WOAŠ =%$=ÀǩAȦ<ɱ% ȧŎnj+Ǖë*Ùʕ(;>=ƚ ą =%('=6ÀǩʏƞĢȍŇ Ɋ$= Ÿ$nj B. gibsoni ŒƐǤ*ƭǧ(
(24) #Ɠƭ+öʚ$=ɈŴ *ɂÌAț4â@=ƭǧƯÀǩŜÉ(+ÐƏǫ%Ȫ ;>#
(25) <[8, 65, 42, 73, 74] FtdK~nVteZO}^sFU*ț4â@+ÀǩǑ *¦ ƭǧƯ%#āé># =[37]* O}^sFU+ B. gibsoni (ƅÐ$<nj B. gibsoni ŒƐǤ*ƭǧ(:ªǗ># =[37, 71, 73, 74] 3Àǩʏƞ*6(¦ǗʅVteZǧƯ%țâ@ƭǧ[65]7Ʌ@># =O}^sFU*ŝʅ8Ɔʊ*ÀǩʏƞÐƏ+§Ȗǫ(ɗ># ' $Ȋ 2 Ȉ$+nj B. gibsoni ŒƐǤ(Ģ=¦ǗʅVteZǧƯŀ* O}^sFUŝ(
(26) =ÀǩʏÐƏ*ƖɒAɅ ;(+ŝƆʊ(ʋ =Ɩɒ%*ɂÌ%*ƧɬAɅ. . 2.
(27) hqUD+Ğ(ŒƐŀƭǧ(:. #48 (ƈƕɄ ;Ƶč=șȡ. ¿ǬȖ(ƾĞ%*ʊ(ǰʋ»ǟAŖȇ#ʤŌŒƐ%'=ˀ7, 14, 59ˁ. B. gibsoni *nj/*ŒƐ+m]cQ_s^fAɆ%=s^f*Êì(:=Œ Ɛ%ɭɄ8ʌnj(:=ß¶'&s^fA' ǯŬ¡ű(:=ŒƐ=[10, 16]ŒƐŀ(7ǩǤƭǧAÞnj$+'ȹDŽôŃ8ƇǩǤ'&$ȫɻ Ăâ(7ʤŌŒƐ%'=ʤŌŒƐnj*ǩǤ(+ȳȷŰÂ8»ǟŜÉǍ œʋ# =[29, 34, 39]ȸĴǒĂ(
(28) =nj B. gibsoni ŒƐǤ*ɕŷ(+Ʉ ƶăŢƖƑ(
(29) =ŒƐÚɃ*ƖÂǗ ;># = ʤŌŒƐ$+ƈ ƕɄ(Âǒ=ŒƐÚɃ*Ŵʝį(ĥ'ʇƖ$+ƖÂöʚ'%7=[7, 24, 43]>;ʤŌŒƐAśů=(+ʫŒĶ'ÃĔǕNJĖǫɕŷŸƯ%# PCRʮpolymerase chain reactionʯǗ ;>=PCR +ƈƕɄ(ŒƐɥɄǓ 10 ° / µl >, B. gibsoni AƖÂàȯ$<nj B. gibsoni ŒƐǤ*ǟĖɝƑ( 7ňǗ># =[24, 25, 64] PCR (7ƖÂʑǚ<ʔŌ$. #7. ŒƐAæę=%+$' *6ʤŌŒƐAƟǹ(ũ; =6(+ PCR (Ï #źľơ7ȪŔ0$=%?nj B. gibsoni ŒƐǤ*ǟĖɝƑ (
(30) #źľơAȪŔ7*+āé># ' nj B. gibsoni ŒƐǤ(
(31) =ʤŌŒƐ*ĚŐAśů=%+Nj(ƲɅü(
(32) =ʤŌŒƐ*ʤŌÒ(:=Àǩ8ƇŒƐnj/*ŒƐ*}WOAġǴ=% (ÐƏǫ%Ȫ ;>ȸĴǫőȩċ >3$ɝƑ># ' $ Ȋ 3 Ȉ$+nj B. gibsoni ŒƐǤ*ƲɅü(
(33) =ǟĖǫǶȄ%#3ȸĴµ ķ'nj* B. gibsoni ʤŌŒƐǍƮAźľơAç6#ɝƑ;(B. gibsoni ŒƐ*}WOmCO]AɏƎ=%%7(ʱ B. gibsoni *ʤŌŒƐnj%ʝŒƐ nj*ɄƶŌǍAƧɬ. 3.
(34) Ȋ 1 Ȉ nj B. gibsoni ŒƐǤƭǧ(
(35) =¦ǗʅVteZǧƯ*ƭǧÐƏ%ė½ Ō*ɗ. 1. ȣɐ ŻƉ(
(36) =njhqUDǤ*Úõ%'. # =*+12ċĊŴ B. gibsoni $. =[25, 46, 52]nj B. gibsoni ŒƐǤ$+B. gibsoni Ğ*ɥɄǓ¿(®¼ ğǕąƤAȦ<ɱ#ɥɄǓAǷĆ*ȝƏ%#Ğ(ƼɄŌɢɄĺ ɧ>=[69] nj B. gibsoni ŒƐǤ*ƭǧ(Ǘ =ŞÚɃɂ(+(VteZǚ$ij ªǗ># =[57, 60] VteZ(+ͨǗ%Àǩ#ɁȃƦŌ ïʣǁ%'. # =ͨǗ+ĤȲÂɄ(:=Ȼëǫ'ǼȜǤǍ8ưģʁ¥*Ǹ. ȝ8ǡǥ'&$=6*ªǗAŕʼn=ǐÔĭ7 =[7, 10, 56, 59] ƃɰ $+ͨǗ*ĥ' ƭǧƯ%#vcf^\~dMUSFO}DVW sFU'& B. gibsoni (ƅÐ% @># =Şȿɂ*ĊÌ©ǗǧƯ[65]Şs |}Dɂ$=DchR(DVWsFUA©ǗocR~[8, 32, 41, 42, 60]3DchR%oPDf~*âÌ%dMUSFO}A©Ǘo cR~[23]'&nj B. gibsoni ŒƐǤ/*Ƙ'ƭǧƯāé># = ŒƐhqUD+>;*ƭǧƯ(:. #7ƽ(§¿ ;Ūʓ>=%. +' [10, 23, 37, 65] nj B. gibsoni ŒƐǤ*ƭǧ(
(37) =VteZ*ŝocR~+ƜȔ$+ 35 mg/kg Øǎ7+ 2 ô*ȌȬ¿ŝ%># =[7, 45, 54, 69] ŻƉù¿$+*Ǘʅ$+ͨǗ%#ǼȜǤǍ'&ɚ6;>āé=[33, 35]*ŀƬ;ĚʪŒƐnjAǗ ǶȄ(:<1.45 mg/kgʗŻ 4 ô* Ǭŝė½'ǗƯ$=%āé#ʐ [50]ŻƉ$+*ocR~= +ʥ¤*¦ǗʅʗŻɈŴôŝ$*ƭǧʮ¦ǗʅVteZǧƯʯƁÜ. 4.
(38) #
(39) <ǒǍ$+ƲɅüAņ( 2 mg/kg *ǬŝAʗŻ$ʶʷôĚŹ# =ǐÔĭĊ ė½ŌAʄɌ¦ǗʅVteZǧƯ(ʋ#+ *ƭǧÐƏ8ͨǗ'&AȸĴǫ(əș'Ɩɒ+># ' $ƉȈ$+nj B. gibsoni ŒƐǤ(
(40) =¦ǗʅVteZǧƯ*ƭǧÐƏ 8ė½ŌAž; (=6(¦ǗʅVteZǧƯ(:<ƭǧAɅ. nj B.. gibsoni ŒƐǤǤ«AĢɡ(ƭǧȚ3$*ɥɄǓȖi|v]ʮRBC, PCV, Hbʯ%ɄĤƍŴʮPLTʯ*ŝȚ3$*ŭǿAɏƎ=%¾(ͨǗ*ǩǕǍ ƮAɝƑ. 2. ƊŶ
(41) :.ŸƯ 2 – 1. ƊŶ 2000 IJ ; 2009 IJ3$(ħßDZê×Ĭ* ÑNJǣʒ(ƋʒƇƭǧ*ŋŌnj. B. gibsoni ŒƐǤ%ɕŷ>ƭǧʉĐŻ(Ȋ 1 ǣŻ)(¦ǗʅVteZǧƯAÞ 242 «AĢɡ%#ɕǧɓʆAôʦǫ(ɝƑŋŌnj B. gibsoni ŒƐǤ* ɕŷ+ȁé8ȸĴǤǍʮʧƝŨ¸ƨ¦3+ɉȽĦ'&ʯɪ§ƖƑŘɋ %%7(ɄƶƖƑ8ĦƖƑŘɋAȪŔ#ºĖʤńʇ$ 1,000 ±*±Ǒ(
(42) #|FcNuTƐȽA
(43) '. ɄƶăŢƙƉ*ɥɄǓ¿( B. gibsoni Ƀ§A. ƖÂĂâ%. 2 2ʲ¦ǗʅVteZǧƯocR~ ¦ǗʅVteZǧƯ+VteZ(LeZ`Oʼgh~aEWDfs~p~Wƒ Ĺ ǻ˂ƌ) 2 mg/kgʗŻ 3 ôʮȊ 1ʱ3ʱ5 ǣŻʯ*ǬŝAɅ. ŲŦǧ. Ư%#VteZŝËŀ(+½«(ndGȕÏʃ}Q~ƶʮ[~|Oc Dʼa~wƒĹ ǻƌʯ510 ml/kg/hr *ʅ*ʜȱ¿ɭƶA 23 ƀʊɅ. 5. .
(44) ɭɄ%ÍȴǬɤr~wʮodf\ưģƶ NZ : ŻƉ½ɂĪƗƒĹ ǻǽ ĩʯŝ+ɕġƀ(ʄĶ*ɢɄ(:. #Ǖë*Ùƚ$=%ÆŷǤ«(Ʌ. . 2 3ʲɝƑŸƯ%ʠǭ';.(Āƻ ¦ǗʅVteZǧƯʉĐƀ*ɔȸĴǤǍCBC (RBC, Hb, PCV, PLT)Ʉ ƶÒĖƖƑĦƖƑ+ɕǧɓʆ:<%<3%6 ūɄ+VteZ*ǬŝË(ʮȊ 1ʱ3ʱ5 ǣŻʯ
(45) :.ŝȚŀ*Ȋ 8 ǣ Ż(Ʌ. Ȋ 1ʱ3ʱ5ʱ8 ǣŻ+VteZŝ(
(46) =ɥɄǓȖi|v]. % PLT *ŭǿAɎġ3ɢɄ*ȀĶ(:=ɥɄǓȖi|v]*ŭǿ* ɼ Až; (=6Ǥ«AʝɢɄȨʮRBC ʿ6.0 × 106 /µlʯ%%7(ɫĶ ɢɄȨʮRBC : 4.05.9 × 106 /µlʯ ȋĶɢɄȨʮRBC : 2.03.9 × 106 /µlʯ ʄ ĶɢɄȨʮRBC : ʽ1.9 × 106 /µlʯ*ʷȨ(ÃȊ 8 ǣŻ3$* RBC *ąƸAɲ ɩ3ɄƶăŢƖƑ+Ȋ 1 ǣŻ%Ȋ 8 ǣŻ* CBC %ãƀ(Ʌ B. gibsoni Ƀ§*ƅǃAɝƑ CBC +ȹÑɄǓɑȎƚʮCelltac-αʼŻƉºʛƒĹ ǻƌʯAǗ #ƖƑ ɄƶÒĖƖƑ+ɄƶÒĖƹęòʮFUJI DRYCHEM 5000V, 7000VʼĠćmF ~uƒĹ ǻƌʯAªǗɄƶÒĖƖƑʠǭ%#+ AST, ALT, ALP, T. Cho, T. Bil, BUN, CRE, Na, K, Cl, Alb, Glu, Ca *ƹęAɅ ÑƹęƚòʮArrows. CRP + CRP ȹ. Laser CRP2ʼDXƒĹ ǻċʎʯAǗ #ƹę. CRP ³ƹęƚò*ʑ 20 mg/dl Aɨ =Ăâ+ 20 mg/dl %#ÁǔʬǠ ŧŴ*ȎÂ+ʬǠŧŴƍʮʬǠŧŴƍʼʫǘvbERƒĹ ǻʼƌʯAǗ ĦƖƑ+ĦƖƑɘʪȗʮJOUzWaE`OWʴʳEAʼDOFƒĹ ǻʼ ƌʯAǗ ɢɄ+ RBC 5.5 × 106 /µl Hb 12.0 g/dlPCV 37 ʭ* ½#Aƺ7*%ɄĤƍƸĥǤ+ PLT 150 × 10ʶ/µl %ę6k }~kĦ+ 2ʰAʖŌ%ʬǠ+ʬǠŧŴ 5 %Ʉȏ¿ƼɄ. 6.
(47) +ɄƷ3+ɄƽȬDzǫ(ƼɄ# Ăâ(ʖŌ%ǩLJ+ 39.7% ". & $. #&%!! . 2 – 4. ȞɑɏƎ VteZ 3 ôŝȚ3$*ɥɄǓȖi|v]';.( PLTs *ȜƀǫĈ Ò+ MannWhitney U test $Ɩę[19]ȞɑÁǔ+½#*ȞɑɏƎ+ Microsoft Excel [mcGHDʮXLSTATʼAddinsoft, New York, USAʯAǗ # ĚŹƅőƩƻ+ 5 ʭ%. 3. ȝƏ ŋŌnj B. gibsoni ŒƐǤ 242 «(
(48) =Åɕƀ*ɔ3+ȸĴǤǍ%# ʧƝŨʮ87.6 ʭʯ%¸ƨƵčʮ83.1 ʭʯʫǑ(ɚ6;>ɉȽĦ7 48.3 ʭ (ɋ;>3ñäʮ9.9 ʭʯǦʮ9.1 ʭʯ§Ōǥʮ14.0 %ʯ7ɚ6;> nj/*s^fdzAɔ%#Þɕnj7 2.9 ʭ(ĕûʮɆ 1 1ʯ Åɕƀ*ȸĴǣǔĖǫNjŅ%#+ɢɄʮ86.4 ʭʯɄĤƍƸĥǤʮ98.3 ʭʯ k}~kĦʮ91.7 ʭʯʫ ǩǕǑAǺ Ÿ$ʬǠ+ 28.5 ʭ$<3 Ʉȏ¿ƼɄ+ 5.0 ʭ$. ǩLJ+ 41.7 ʭ(ɚ6;>ʮɆ 1 2ʯáɥɄ. ǓȖi|v]*ȳ+>> RBCs 3.46 × 106 /µlʮĀƻȒ÷ʼ5.50 ~ 8.85 × 106 /µlʯ Hb 7.9 g/dlʮĀƻȒ÷ʼ12.0 ~ 20.5 g/dlʯ PCV 24.0 ʭʮĀƻȒ÷ʼ 37 ~ 61 ʭʯ$. 3 PLTs *ȳ+ 43 × 10ʶ /µlʮĀƻȒ÷ : 150.0 ~ 485.0. × 10ʶ /µlʯ$. ʮø 1 1ʯ Åɕƀ*ɄƶÒĖƖƑ*ȳ+ ALP % CRP. ʫ³AǺʮɆ 1 3ʯ. 7.
(49) ¦ǗʅVteZǧƯA ½ 242 «13 Ǥ«ȊʺǣŻ3$(Ƣ 3Ç*ʹǤ«(+Ȋ 8 ǣŻ3$(ɭɄĚŹ>3Ȋ 8 ǣŻ3$(+À ǩ«+ɚ6;>'. ɥɄǓȖi|v]% PLT *ŭǿ(! #+Ƣ«%. ɭɄ«Aʓ 222 «(! #ɝƑ* 222 «½#*Ǥ«ƭǧʉĐŀ. B. gibsoni Ƀ§+ɷ8 (ƵɳɢɄ%ɄĤƍƸĥ*ôŃ(¢ #Ȋ 8 ǣŻ( +ȸĴǤǍ*Ƶč%§ɝ*ôŃAǺ3ɄƶăŢƖƑ(
(50) =Ȋ 8 ǣŻ$ * B. gibsoni Ƀ§*ƖÂ+ 222 «*½«$ǹɚ=%$'. . Ȋ 8 ǣŻ3$*ɥɄǓȖi|v]*ŭǿAø 1 2 (ǺRBC +Ȋ 1 ǣŻ(Ƨ0#Ȋ 3 ǣŻ(+ƅő(Ƹĥʮp < 0.05ʯ3ȊʸǣŻ( Hb Ȋ 8 ǣŻ(+½#*i|v]Ȋ 1 ǣŻ:<ƅő(ąÏȊ 8 ǣŻ3$* RBC AʝɢɄȨɫĶȀĶʄĶɢɄȨ* 4 Ȩ(Ã#ąƸAɲɩȝƏA ø 1 – 3 (Ǻ ʝɢɄȨ$+ȊʶǣŻ(ɫĶɢɄȨ$+Ȋ 3
(51) :.Ȋ 5 ǣŻ * RBC *ƅő'Ƹĥɚ6;>ʮp < 0.05ʯ ȋĶ
(52) :.ʄĶƸĥȨ$ +ȊʶǣŻ*ƅő'Ƹĥɚ6;>'. *ŀȋĶʄĶƸĥȨ$+Ȋ. 5 ǣŻʐ*ƅő'ąÏɚ6;>ʮp < 0.01ʯPLT *ŭǿ+ø 1 4 (Ǻ 3ʱ5ʱ8 ǣŻ%ȜŻƥ(ƅő(ąÏʮp < 0.01ʯ ¦ǗʅVteZǧƯAÞ 242 Ǥ«*ͨǗ*¿ĝ%*ǩǤǍƮAɝƑ %?ǼȜǤǍAǩǒǤ«+½ɚ6;>'. ưģʁ¥*Ǹȝ8ǡ. ǥ 9 «ʮ3.7 ʭʯ(ɚ6;>Ȋ 8 ǣŻ3$*Ƣ«+ 13 «ʮ5.4 ʭʯ$ *ƢǔǙ+ȴ½ 5 «ƿ Ʉȏ¿ƼɄ 2 «»ǟûŌƼɄŌɢ ɄʮIMHAʯ*©ǩ 4 «$<>;+ƭǧË*Åɕƀ*ƖƑ$$(ɚ6;> # 3¦ǗʅVteZǧƯAÞ#7ɢɄ8ȸĴǤǍųð(Ƣ. 8.
(53) «+ 2 «$. . 4. Ȫġ ƉǶȄ$+nj B. gibsoni ŒƐǤ(
(54) =¦ǗʅVteZǧƯ*ƭǧÐƏÜ. ė½Ō*ɗAɅ 63Ģɡ%'=ƲɅü$*nj B. gibsoni ŒƐǤ*ȸĴŐ āAɝƑÅɕƀ*ɔÜ.ȸĴǤǍ$+ʧƝŨ8¸ƨƵčʫ ǩǕʢĶ $<ǩLJ8ɉȽĦ+ÖŴAɨ =1&$+'3ñä8Ǧ
(55) :.§Ōǥ ¦ ǩǕʢĶ(=%ǹɚ$ȸĴǣǔŘɋ%#ɢɄ8ɄĤƍƸĥǤ k}~kĦ+ʝį(ʫ ǩǕʢĶ$ɚ6;>ʬǠ+ ȼǫ$' ȏ¿ƼɄ+ 5.0ʭ%¦ ǩǕʢĶ$. Ʉ. . nj B. gibsoni ŒƐǤ*ƼɄ*vKfXu+ÚɃ*ɥɄǓ/*ŒƐąƤ(:= ǷĆ8ɥɄǓ*ƴɵúšŞ*¦(:=ɥɄǓȶ*ȰĻÒ(:=Ʉȏ¿ƼɄȪ ;># [75] ȸĴǫ(+¦ ÚɃğǕǑ$7ɢɄʄǤÒ=% ŧŰ># =6[75]ŞɥɄǓȶާǖǕ(:=sOmCV8 NK șȮ '&*ɥɄǓɣʧ*ƚ *ąÏ8[2, 5, 38, 47]ɥɄǓ*ʃÒʙě[49]'&ǯŬǫ 'ɥɄǓ/*ʙěĉ*vKfXu7Ůî># =>;*ɥɄǓ+ȳȷ8ș ȡ¿ǬȖ$Ūʓ>=[48, 54];(ŞɥɄǓȶާ*ąÏ+ B. gibsoni ʝŒƐ ɥɄǓ(7ȝâʙěA =%ÚɃğǕǑ¦#7ɢɄʄĶ('= Úõ%Ȫ ;># =[55]>+ IMHA (
(56) =ɄȏĉƼɄ*ƚĵ%ʥ¤# =[12, 75]ô+ğǕǑ*ɝƑ+Ʌ@># ' 6ğǕǑ%ƼɄ*ŒƐŌ+ ž$. Ʉȏ¿ƼɄ$>,ɄȽȘĦAè[12]ɄȏĉƼɄ+k}~. kĦ%#Ýſ=6ɄȏĉƼɄ*ǩǕʢĶ+ɀʫ %Ǻí> ɄƶÒĖƖƑ$+ ALP *ąÏɚ6;>*Úõ+ȧŎWcW(ɧõ=¿. 9.
(57) õŌR~_\~(:=7*%Ŋ@>[13, 28]3 CRP ³*ąÏ7ɚ6;>Ł Ƌ*nj B. gibsoni ŒƐǤ$āé># =ȸĴǣǔŘɋ%ãƘ(NjŅǫ'¹²$ =%ôÀǹɚ>*% ;ô*Ǥ«Ȩ+¦ǗʅVteZ ǧƯ*ƭǧÐƏ%ė½ŌAɗ=ƉȈ*ƊŶ%#+´<'ɽÄ'7*% Ȫ ;> [7, 27, 28, 35, 40, 51, 52, 65] ƛ(¦ǗʅVteZǧƯ(
(58) =VteZ 3 ôŝȚŀ3$*ÐƏ(! #ɝƑɥɄǓȖi|v]+Ȋ 3 ǣŻ( RBC ƅő(Ƹĥ#Ȋ 8 ǣŻ (+Ȋ 1 ǣŻ:<ƅő(ąÏȊ 3 ǣŻ* RBC *ʐ+ B. gibsoni Vte Z(:. #ʩɃ>ŒƐɥɄǓÁǔ>6%Ŋ@>=:. #ƭǧÅƆ. +ɢɄ*ɹɅ'&ȧŎnj*§ɝ ƀǫ(ŏÒ=àȯŌAưő0$= Ȋ 8 ǣŻ(+½#*i|v]ƅő(ąÏɢɄ*ȀĶA 4 Ȩ(à $ʝɢɄȨ%ɫĶƸĥȨ$+ȊʶȊʸǣŻ(ƅő(ʐ#
(59) <ȋĶ ʄĶƸĥȨ+ɴ(ȊʸǣŻ ;ƅő(Ž#
(60) <ɢɄȋĶ ;ʄĶ*Ăâ +ƭǧ(:. #ɢɄ*ɹɅŜÉ>%Ȫ ;>:. #¦ǗʅVteZ. ǧƯ$+ƭǧʉĐ ;ɥɄǓȖi|v]ôŃ(å (+
(61) : 4 ŻËŀŇ Ɋ'%*ƀ(ɢɄ' = +ɫĶ*Ăâ+ɢɄ ƀǫ(ɹɅ #
(62) <ʄǤ*Ăâ(+48 (ôŃAǺ%Ɖƭǧ*Ɵ ŧƙ%#dž Ǵ#
(63) 0$= Åɕƀ*ɄĤƍƸĥǤ+ 98 ʭ*Ǥ«(ɚ6;>PLT +Ȋ 8 ǣŻ3$ƹę ƥ(ƅő'ąÏɋ;>¦ǗʅVteZƭǧ(
(64) # ƀǫ(Ƹĥ=ɥɄ ǓȖi|v](Ƨ0#PLT +ƭǧ(:<ȜŻǫ(ąÏ=%Ǻ> ¦ǗʅVteZǧƯ(
(65) =ͨǗ*ǩǕǑ
(66) :.ƢǑ(! #ɝƑ. 10.
(67) VteZ*ͨǗ+ĤȲÂɄ%ưģʁ¥*Ǹȝ8ǡǥ=% @>#
(68) <Nj (ĤȲÂɄ+Ȼëǫ$=[10]ƉǶȄ*ŝƯ+ͨǗôʀ*6(ȪƔ> 7*$=ȸĴ«$ȖȞǫ(ɗ># ' [50]ĊŴ*ȸĴ«AĢɡ( ô*ɝƑ$+ǼȜǤǍAǩǤǤ«+' # '. 6Ȼëǫ'ĤȲÂɄ+ɧ. %Ŋ@>=ưģʁ¥*Ǹȝ8ǡǥ+ 3.7 ʭ(ɚ6;>$. <¦ǗʅVteZǧƯ+ė½Ō*ʫ ƭǧƯ$=%ǹɚ$3ʱ Ƣ« 13 «*ǔǙ%#ȴ½ 5 «%ƿ Ʉȏ¿ƼɄ 2 «IMHA *©ǩ 4 «ƭǧ(Ýň'. ʄȓ'ɢɄƢʵ«$. >;+nj B. gibsoni Œ. ƐǤ*Ȼëǫ'ǤǍ%#āé># =[31, 76]ƉɝƑ$+ȴ½Ʉȏ¿ƼɄ Ü.ʄȓ'ɢɄ+¦ǗʅVteZǧƯË(Ǖ# =6VteZŝ%* ǯŬǫ'õƏʋ¯+'VteZ*ͨǗ$+' %Ŋ@>;(ɭɄA Ź>Ç* 7 Ǥ«Aʓĉ=%ô*ɝƑ$+ 222 «¦ǗʅVteZǧƯ (:. #Ȋ 8 ǣŻ3$(ôŃAǺɄƶăŢƖƑ(:=ğǕɃɄǤ7ɚ6;>' :. #¦ǗʅVteZǧƯ(:=ôŃǑ+ 91.7 ʭ%ȎÂ>3. Ȋ 8 ǣŻ3$(+Àǩ+½«(ɚ6;>' Ɔʊǵ 6ƅÐŌ3$+ǹɚ$'. ƉǶȄ$+Àǩ*Ɏġ. *ƭǧƯ*ôŃǑ+Vte. ZʫǗʅǧƯʮ35 mg/kgʯ$+ 91.7ʭ [33]DchR(DVWsFU A©ǗŸƯ$+ 90.9ʭ[8]DchR%oPDf~*âÌ(dMUSFO} *©ǗŸƯ$+ 100ʭ[23]$<¦ǗʅVteZǧƯ*ôŃǑ+>; *ƭǧ%ãȋ%Ŋ@> *Ǵɋ ;ƲɅü$ɝƑnj B. gibsoni ŒƐǤ(
(69) =¦ǗʅVteZ ǧƯ+ɢɄ żɹɅ=7**ųð*ƭǧƯ%ãȋ*ôŃǑAǺ. 11.
(70) >3$*VteZ*ªǗƯ$ŕʼn>Ȼëǫ'ͨǗAǩǕ' %Ǻ >. 12.
(71) 5. Ĥť nj B. gibsoni ŒƐǤ(
(72) =¦ǗʅVteZǧƯ*ɗAɅ 6ȸĴŐāA ôʦǫ(ɏƎ#Ɩɒ3¦ǗʅVteZǧƯ*Ģɡ%'=ŻƉ*ƲɅü $*nj B. gibsoni ŒƐǤ*ȸĴŐāAɝƑÅɕƀ(+ʧƝŨ8¸ƨƵč ʫ ʢĶ$=1 (ǩLJ8ɉȽĦ+ÖÃ1&(3ñäǦ8§Ōǥ¦ʢ Ķ(=%ǹɚ$ȸĴǣǔŘɋ%#ɢɄ8ɄĤƍƸĥǤk}~k Ħ+ʝį(ʫ ʢĶ$ɚ6;>=ʬǠ8Ʉȏ¿ƼɄ+ ȼǫ$'. . ƛ(¦ǗʅVteZ 3 ôŝ(
(73) =ÐƏAɝƑ3ɥɄǓȖi|v ]% PLT *ȜɻAɲɩɥɄǓȖi|v]+Ȋ 3 ǣŻ( ż¦ #Ȋ 8 ǣŻ(+ôŃ Ÿ$ PLT +ȜŻƥ(Žƭǧ*ÐƏƹ%# ÈǗ$=àȯŌǺ>3 RBC A 4 Ȩ(@#ôŃ3$*əșAɝƑ *ȝƏRBC +Ȋ 8 ǣŻ*Æę3$*ʊ(ʝɢɄȨ+ ż¦=ʄĶ ɢɄȨ+ȜŻƥ(ަǗʅVteZǧƯ$+ɢɄ*ʄǤĶ(ň#ôŃ( ɼ =%Ǻ>Ɖƭǧ(
(74) =ͨǗ+ 3.7 ʭ(ŬȂʁ¥*Ǹȝ8ǡ ǥ=ǼȜǤǍ+½ɚ6;>'. 242 « 222 «Ȋ 8 ǣŻ3$(. ôŃAǺôŃǑ+ 91.7 ʭ%ȎÂ>:. #ƲɅü$*nj B. gibsoni Œ. ƐǤ(
(75) =¦ǗʅVteZǧƯ+ƭǧÐƏʫė½'ŸƯ$=%ȝɞ> . 13.
(76) Ɇ 1 1. ŋŌnj B. gibsoni ŒƐǤAǩǤnj 242 «(
(77) =¦ǗʅVt eZǧƯʉĐƀ*ɔ / ȸĴǤǍ ɔ / ȸĴǤǍ. . ǩǕŴ. %. ʧƝŨ. 212. 87.6. ʮ 212 / 242 ʯ. ¸ƨƵč. 201. 83.3. ʮ 201 / 242 ʯ. ɉȽĦ. 117. 49.9. ʮ 117 / 242 ʯ. ñä. 24. 15.4. ʮ 24 / 242 ʯ. Ǧ. 22. 14.1. ʮ 22 / 242 ʯ. §Ōǥ. 34. 12.0. ʮ 34 / 242 ʯ. s^fdz. 7. 2.8. ʮ 7 / 242 ʯ. 14.
(78) Ɇ 1 2. ŋŌnj B. gibsoni ŒƐǤAǩǤnj 242 «(
(79) =¦ǗʅVt eZǧƯʉĐƀ*ÅɕƀȸĴǣǔĖǫŘɋ ɔ / ȸĴǤǍ. ǩǕŴ. %. ɢɄ. 209. 86.4. ʮ 209 / 242 ʯ. ɄĤƍƸĥǤ. 238. 98.3. ʮ 238 / 242 ʯ. k}~kĦ. 222. 91.7. ʮ 222 / 242 ʯ. ʬǠ. 69. 28.5. ʮ 69 / 242 ʯ. Ʉȏ¿ƼɄ. 12. 5.0. ʮ 12 / 242 ʯ. ǩLJ. 101. 41.7. ʮ 101 / 242 ʯ. 15.
(80) Ɇ 1 3.. ŋŌnj B. gibsoni ŒƐǤAǩǤnj 242 «(
(81) =¦ǗʅVte. ZǧƯʉĐƀ*ɄƶÒĖƖƑȝƏ . . ƹęŴ. ȳ. ÛȪ³*. T.P. ( g/dl ). 242. 6.4. (. 6.0. . 8.0. ). AST. ( U/l ). 223. 43.0. (. 9. . 69. ). ALT. ( U/l ). 223. 39.0. (. 13. . 53. ). ALP. ( U/l ). 223. 356.0. (. 14. . 142 ). T. cho. ( mg/dl ). 223. 198.5. (. 70. . 303 ). T. Bil. ( mg/dl ). 242. 0.7. (. 0.3. . 0.9. BUN. ( mg/dl ). 242. 16.4. (. 4.8. 31.4 ). Cre. ( mg/dl ). 242. 0.6. (. 0.2. . 1.6. Na. ( mEq/l ). 137. 146.0. (. 137. . 150 ). K. ( mEq/l ). 137. 4.0. (. 3.4. . 5.2. Cl. ( mEq/l ). 137. 111.0. (. 102. . 117 ). Glu. ( mEq/l ). 201. 100.0. (. 50. . 124 ). Alb. ( g/dl ). 242. 2.8. (. 2.6. . 3.3. Ca. ( mg/dl ). 201. 8.7. (. 7.9. 12.2 ). CRP**. ( mg/dl ). 111. 13.5. (. 0.0. . 1.0. * ƹęƚòvK*ŭĎ=ÛȪĀƻȒ÷[67]AǗ ** CRP ³ƹęƚò*ʑǚʮ20 mg/dlʯAɨ =Ăâ+ 20 mg/dl %. 16. ). ). ). ). ).
(82) ( x106/µl). (%). (g/dl). 25.0. 9.00. ( x103/µl). 400. 60. 8.00 20.0. 7.00. 350. 50. 300 40. 6.00. 250. 15.0 5.00 30 4.00. 200. 10.0. 150. 20. 3.00. 100. 2.00. 5.0. 10. 50. 1.00 0 0.00. ø 1 1.. RBC RBC. 0.0 0. 0 Hb. PCV. 0. PLT PLT. ŋŌnj B. gibsoni ŒƐǤAǩǤnj 242 «(
(83) =¦ǗʅVteZ. ǧƯʉĐƀ* RBCʮɥɄǓŴʯ, HbʮpwPk³ʯ, PCVʮɄƶĝȃʯ, PLT ʮɄĤƍŴʯ*ȳ*Ȑ-øȐ*Č*Ȥ+ȳþȤ+jQ*ȉ+ƃ ċ³ȉ+ƃĤ³AǺ. 17.
(84) ( x106 / µl ) RBC. 8.00 . 6.00 4.00. . 2.00 0.00 0 Hb. ( g / dl ). 1. 3. 5. 8. 15. . 10 5 0 (%) PCV. 50 40 30 20 10 0. . 01. 3 2. 5 4. 78. . ø 1 2. ¦ǗʅVteZǧƯA ŋŌnj B. gibsoni ŒƐǤ 222 «(
(85) = VteZ 3 ôŝʮȊ 1, 3, 5 ŻʯȚŀʮȊ 8 Żʯ3$* RBCʮɥɄǓŴʯ, Hb ʮpwPk³ʯ, PCVʮɄƶĝȃʯ*Ȋ 8 ǣŻ3$*ŭǿásK*þȤ +ƙƻ´īAǺDW]}WO+>>*ƖƑ³Ȋ 1 ǣŻ*ƖƑ³%*ƅő ī=%AǺʮ* ʾ p < 0.05,. ** ʾ p < 0.01ʯ. 18.
(86) (x106/µl). . 8.00. .
(87) . . 7.00 . . 6.00 5.00. . . 4.00. . . 3.00 2.00 1.00 0 0.00. 1. 3. 5. 8.
(88) . ø 1 3. ¦ǗʅVteZǧƯA ŋŌnj B. gibsoni ŒƐǤ 222 «(
(89) = VteZ 3 ôŝʮȊ 1, 3, 5 ŻʯȚŀʮȊ 8 Żʯ3$*ʝɢɄȨɫĶɢɄȨ ȋĶɢɄȨʄĶɢɄȨ* RBCʮɥɄǓŴʯ*ŭǿásK*þȤ+ƙƻ´ īAǺDW]}WO+>>*ƖƑ³Ȋ 1 ǣŻ*ƖƑ³%*ƅőī= %AǺʮ* ʾ p < 0.05,. ** ʾ p < 0.01ʯ. 19.
(90) . 400. 300. 200 . 100. 0 1. ø 1 4.. 3. 5. 8. . ¦ǗʅVteZǧƯA ŋŌnj B. gibsoni ŒƐǤ 222 «(
(91) . =VteZ 3 ôŝʮȊ 1, 3, 5 ŻʯȚŀʮȊ 8 Żʯ3$* PLTʮɄĤƍŴʯ *ŭǿásK*þȤ+ƙƻ´īAǺDW]}WO+>>*ƖƑ³ Ȋ 1 ǣŻ*ƖƑ³%*ƅőī=%AǺʮ** ʾ p < 0.01ʯ. 20.
(92) ȊʵȈ nj B. gibsoni ŒƐǤ*Àǩʏƞ(ʋ=ǶȄ. ȣɐ nj B. gibsoni ŒƐǤ+B. gibsoni ɥɄǓ(®¼#ąƤAȦ<ɱ%( :<ƼɄĺɧ>#ɢɄAŅ%=ǢŎ$=nj(Ģ= B. gibsoni * ǣÚŌ+ļŒƐnj$+¸ƨʧƝ*¦ɢɄǩLJʬǠȳȵ'&ɚ6; >=[69]3nj B. gibsoni ŒƐǤ$+ÀǩĊ %Ǵ;># =[4, 10] nj B. gibsoni ŒƐǤ*ƭǧɂ(+Ƙ'7*=B. gibsoni AŒƐnj*§¿ ;ƽ(Ūʓ=ƓƭǫƭǧƯ+ 3āé># ' [10, 23, 37, 65]ŻƉ $+nj B. gibsoni ŒƐǤ*ƭǧɂ%#(VteZªǗ># =Í ¨Ǘ%#ĤȲÂɄ8ưģʁ¥*Ǹȝ8ǡǥɧ=%Ǵ;># =[7, 10, 29, 58, 60]Ȋ 1 Ȉ$+*ͨǗAôʀ=6(ǒûijƁÜ># =¦Ǘ ʅVteZǧƯ*ôŃǑ%ė½ŌAɗ#ƅÐ$=%Až; ( ¦ǗʅVteZǧƯ$7ÀǩǕ=%+ʀ;>ɈŴô*ƭǧA ŇɊ%=Ăâ(+VteZ*ɁȃƦŌ8ȫŌƒ*Âǒŕʼn>=[57,58] ŸB. gibsoni *ąƤAŜÉ=ŞȿɂɈŴāé>#
(93) <[44, 65, 74] À ǩʏƞ*6(¦ǗʅVteZǧƯ%©Ǘ=ŸƯɘ4;># =[65]% (O}^sFU+¦ǗʅVteZǧƯŀ*Àǩʏƞɂ%#:ªǗ> # = O}^sFU*ŝʅ8Ɔʊ*ÀǩʏƞÐƏ'&+§Ȗǫ (ɗ>#' $ƉȈ$+Ȋ 1 ȑ(
(94) #nj B. gibsoni ŒƐǤ(Ģ=¦ǗʅVteZ ǧƯŀ*O}^sFUŝ*ÀǩʏÐƏAƖɒ3Ȋ 2 ȑ$+¦Ǘ ʅVteZǧƯŀ*O}^sFUĉ*Şȿɂ%#B. gibsoni ÐƏAƅ =DVWsFU%dMUSFO}(
(95) =ÀǩʏƞÐƏAƧɬƖɒ. 21.
(96) Ȋ 1 ȑ ¦ǗʅVteZǧƯ%O}^sFU*ț4â@ƭǧƯ*nj B.. gibsoni ŒƐǤÀǩʏƞÐƏ*Ɩɒ. ʴʲĵɞ O}^sFU+}RsFUȖŞǕNJɤ$<ndGǓȿ8ēƨŌȿ' &*șȿŒƐ(Ǘ ;>=[56]cM[o|Xs8s|}D(7Ǘ ;>#
(97) < ŞÚɃ¨ǗAƅ=%āé># =[51, 69]B. rodhaini ŒƐ(Ģ#+ ɣʧÐƏ%sOmCV*ÒĖɦŌAʫ6#»ǟÎA# =%Ȫ ;># = [72] *6O}^sFU+nj B. gibsoni ŒƐǤ*¦ǗʅVteZǧƯ*À ǩʏƞɂ%#:ªǗ># = O}^sFU*ŝʅ8Ɔʊ *ÀǩʏƞÐƏ'&+§Ȗǫ(+ɗ># ' *6Ɖȑ$+nj B.. gibsoni ŒƐǤ(Ģ=¦ǗʅVteZǧƯŀ*O}^sFUŝ*Àǩʏ ƞÐƏAƖɒ. 2ʲƊŶ
(98) :.ŸƯ 2000 IJ ; 2009 IJ3$(ħßDZê×Ĭ* ÑNJǣʒ(ƋʒƇƭǧ*ŋŌnj. B. gibsoni ŒƐǤ 242 «* VteZ(LeZ`Oʼgh~aEWDfs~p ~WƒĹ ǻ˂ƌ) 2 mg/kg *ǬŝAƭǧʉĐ ;ʗŻʮ48 ƀʊ%ʯ(ʶô ŝAÞ 222 «AĢɡ%Ģɡnj+ƭǧʉĐŻAȊ 1 ǣŻ%#Ȋ 8 ǣ Ż(0#§ɝ*ôŃAǺ# =VteZÅôŝƀ(+½«(ŲŦǧƯ% #ndGȕÏʃ}Q~ƶʮ[~|Oc Dʼa~wƒĹ ǻƌʯ510 ml / kg / hr *ʅ*ʜȱ¿ɭƶAVteZŝËŀ( 23 ƀʊɅ. '
(99) ɭɄ3. +ÍȴǬɤr~wŝAĚŹǤ«+ƉǶȄ(+ç6# ' nj B.. 22.
(100) gibsoni ŒƐǤ*ɕŷ+ȸĴǤǍʮʧƝŨ¸ƨ¦3+ɉȽĦ'&ʯ( Ï #ºĖʤńʇ$ 1,000 ±*±Ǒ(
(101) #|FcNuTƐȽA
(102) ' ɄƶăŢƙƉ*ɥɄǓɆʞ( B. gibsoni Ƀ§AƖÂĂâ% Àǩʏƞɂ%#O}^sFUʮ^|UʼmCFTƒĹ ǻƌ25 mg/kgʴŻʵôʯ*ȜßŝAȊ 8 ǣŻ ;Ȋ 29 ǣŻ3$ȟȠŝO} ^sFU*ŝĢɡnj+ǃ¨ǂ(ţÂʨ (ɜž*ãőAł 80 « %ʮDC Ȩʯƣ<* 142 «+Ȋ 29 ǣŻ3$ǃŝɂ%#ĢDžȨ% ƉɝƑ+ɕǧɓʆ(:<ôʦǫ(%<3%6;>Àǩ+¦ǗʅVteZ ǧƯŀ ĶƵčnj B. gibsoni ŒƐǤ(ɚ6;>=ɢɄǩLJ¸ƨʧƝ¦ ȳȵ'&*ȸĴǤǍAÀ.èɄƶăŢƙƉ$Ƶč# B. gibsoni ÀƖ >Ăâ%ɕġ+ 710 Żƥ(Ʌ@>ɶ(ȸĴǤǍɚ6;>nj$ +Àǩ*ǹɚAɅ. Ȋ 29 ǣŻ3$(Àǩ%Æę>ʘ(+Ȋ 29 ǣŻ3$. ȜɻAɎġŀ(nj B. gibsoni ŒƐǤƭǧAɅ. . ƖƑʠǭ+Ȋ 1, ʺ, 29 ǣŻ( RBC, Hb, PCV, PLT
(103) :. CRP Awf] RBC, Hb, PCV, PLT +ȹÑɄǓɑȎƚʮCelltac-αʼŻƉºʛ
(104) ƌʯ AǗ CRP + CRP ȹÑƹęòʮArrows Laser CRP 2ʼDX
(105) ċʎʯAǗ #ƹęCRP ³ƹęƚò*ʑ 20 mg/dl Aɨ =Ăâ+ 20 mg/dl %#Áǔ Ȋ 29 ǣŻ(
(106) =O}^sFUƭǧŀ*ÀǩǑ+KFƖęAǗ #ɝ 0Ȋ 18ʱ29 ǣŻ* DC Ȩ
(107) :.ĢDžȨ* RBC, Hb, PCV, PLT
(108) :. CRP *ƅőī;( RBC, Hb, PCV, PLT
(109) :. CRP *ÀǩȨ%ʝÀǩȨ*ī+ One Way ANOVA[19]$ƖęȨ*ÀǩŻ*Ƨɬ7ãƖęAǗ ½#*Ȟɑ ɏƎ+ Microsoft Excel [mcGHDʮXLSTATʼAddinsoft, New York, USAʯA Ǘ #ĚŹƅőƩƻ+ 5ʭ%. 23.
(110) 3ʲȝƏ ƉɝƑ(
(111) =Ģɡnj+¦ǗʅVteZǧƯ(:. #Ȋ 8 ǣŻ3$(§ɝ*. ôŃ%ɄƶăŢƙƉ(:=ğǕɃɄǤ*ƵčAɚ6Àǩ+ĢDžȨ* 142 « 42 «ʮ29.6 ʭʯ(Àǩɋ;>*(ĢDC Ȩ$+ 13 / 80 «ʮ16.3 ʭʯÀǩ DC Ȩ*ÀǩǑ+ĢDžȨ*ÀǩǑ:<7ƅő(¦. ʮp < 0.05ʯDC Ȩ.
(112) :.ĢDžȨ*ıýÀǩŻ+>> 27.4 ± 1.0 Ż
(113) :. 27.5 ± 0.8 Ż$< ƅőī+'. . DC Ȩ%ĢDžȨ*Ȋ 1, 8, 29 ǣŻ(
(114) =áƖƑ³AɆ 2 1 (ǺȊ 1 ǣ Ż( DC Ȩ%ĢDžȨ%*ʊ$ RBC, PCV, Hb, PLT
(115) :. CRP (Ȟɑǫ'ī+ɋ; >'. Ȋ 8 ǣŻ$+ĢDžȨ%Ƨɬ#DC Ȩ* RBC +¦³$. PCV, Hb, PLT
(116) :. CRP (+ƅőī'. Ȋ 29 ǣŻ$+DC Ȩ*. RBC
(117) :. PCV *ıý³+ĢDžȨ%Ƨɬ#ƅő(ʫ
(118) :. CRP * 2 Ȩʊ*ƅőī+'. . Hb, PLT. . 3 DC ȨĢDžȨ$*ÀǩȨ* RBC, PCV, Hb
(119) :. PLT *Ȋ 29 ǣŻ*ıý ³+ʝÀǩȨ:<ƅő(¦CRP *ıý³+ʝÀǩȨ%Ƨɬ#ƅő(ʫ. . ;(DC Ȩ%ĢDžȨ*ÀǩȨ(
(120) =Ȋ 1 ǣŻ* RBC % Hb *ıý³%Ȋ 8 ǣŻ* RBC % PCV *ıý³+DC ȨĢDžȨ:<ƅő(¦. (7 @;. Ȋ 29 ǣŻ* RBCPCV
(121) :. Hb *ıý³+ DC ȨĢDžȨ:<ƅő(ʫ '
(122) ɘʪƆʊO}^sFUŝ(:=%4;>=ͨǗ+ɚ6;> '. . 4ʲȪġ. 24.
(123) nj B. gibsoni ŒƐǤ*ƭǧ(+Ø *ɂÌ:<ɈŴ*ɂÌ*ț4â@(:=ƭ ǧƯ*ŸÐƏǫ$=%Ǵ;># =[37]ô+ B. gibsoni ŒƐ(Ǘʅ¬ ĕǫ(ƅÐ'ŞǕNJɤ$=O}^sFU(ưǭ[37, 71, 73, 74]*Àǩ ʏƞÐƏAɲɩɝƑô*ȝƏ ;DC Ȩ*ÀǩŻ+ĢDžȨ%ī+' ÀǩǑ+ĢDžȨ%Ƨɬ# DC Ȩƅő(¦. ɄƶƖƑ(:= DC Ȩ. %ĢDžȨ%*Ƨɬ$+Ȋ 1 ǣŻ$+ī'Ȋ 8 ǣŻ( DC Ȩ* RBC ƅő (Ƹĥ# =7**DC Ȩ* RBC +Ȋ 8 ǣŻ(Ƹĥ*i|v] 8§ɝ*ôŃ(ī'. >;+ȨÃ*ǃ¨ǂŌAǹɚ=ȝƏ%'. . ;(DC Ȩ+ĢDžȨ:<ȊʵʻǣŻ$+ RBC % PCV ƅő(ąÏ#
(124) < Àǩnj(
(125) =ɢɄ+ĢDžȨ%Ƨɬ#ɫĶ$. *% ;¦ǗʅV. teZǧƯ(O}^sFUAț4â@Ÿǩǣ ;ɢɄ*ôŃ8Àǩ ƀ*ʄǤÒ*ŜÉ(7ĽʟAÜ2# =àȯŌȪ ;>ô*O}^s FUŝʅ+Ơêǣ'&(ªǗ=Ǘʅʮ5mg/kg 1 Ż 2 ôʯ:<7ʫǗʅ$ . [18]DC Ȩ(+ʤɀ'ͨǗ+ɋ;>*ė½Ō(ïʣ' %. Ǻí>>;*Ǵɋ ;VteZ%O}^sFU(:=ț4â@ *ƭǧ+Àǩʏƞ*ƭǧ*ɾşȭ%#ƅÐ !ė½'ŸƯ$=%Ŋ@>. 25.
(126) Ȋ 2 ȑ DVWsFU%dMUSFO}*nj B. gibsoni ŒƐǤÀǩʏƞÐƏ *Ɩɒ. 1ʲĵɞ Ȋʴȑ$+¦ǗʅVteZǧƯ%O}^sFU*ț4â@ƭǧ(:= ÀǩʏƞÐƏAɖžŞÚɃÐƏAƅ=ɂÌ%#+(7DVWsF U%dMUSFO}āé>#
(127) <nj B. gibsoni ŒƐǤ*ƭǧ(7ňǗ ># =[7, 44, 65, 66, 68] Ȋ 2 ȑ$+nj B. gibsoni ŒƐǤ(
(128) =DVWsFU%dMUSFO} *¦ǗʅVteZǧƯŀ*ÀǩʏƞÐƏ(! #Ɩɒ3ŝƆʊAĸ ʈ%*ƅÐŌAɗ=6(Ȋ 1 ȑ* 28 Żʊ:<7ɂÌ*ŝƆʊA ĸʈ#ÀǩʏƞÐƏ(! #ƖɒAɅ. . ʵʲƊŶ
(129) :.ŸƯ ƉǶȄ+ 3 !*ƭǧƯAƧɬËåǶȄ%#Ʌ. ʝǮƖ*ȸĴɘʪ$. =ƊŶ+ 2010 IJ ; 2017 IJ*ʊ(ƲɅü$=ħßDZê×Ĭ* ÑNJǣʒ(Þ ɕ#Åǩ*ŋŌnj B. gibsoni ŒƐǤ%ɕŷ> 140 ʡ*nj%* 140 ʡ+ÅƆƭǧ(¦ǗʅVteZǧƯ%#Ȋ 1 ǣŻ(VteZʮLeZ` Oʼgh~aEWDfs~p~WƒĹ ǻƌʯA 2 mg/kgʗŻ 3 ô*Ǭư ģAɅ. *ŀȊʺǣŻ ;ɇƖɂAȜßŝɇƖɂ+DVWsF. UʮVWs`OʼmCFTƒĹ ǻƌ10 mg/kg1 Ż 1 ôȜßŝʯ dMUSFO}ʮkn|sFUʼmCFTƒĹ ǻƌ10 mg/kg1 Ż 2 ôȜßŝʯ3ĢDž%#Ȋ 1 ȑ$Ǘ O}^sFUʮ^|Uʼ mCFTƒĹ ǻƌ25 mg/kgʴŻ 2 ôȜßŝʯ* 3 ȂʥAªǗ ŝƆʊ+1 ƄŝȨ+ȊʺǣŻ ;Ȋ 29 ǣŻ3$3 ƄŝȨ+ȊʺǣŻ ;Ȋ 84 ǣŻ3$%ɇƖȨ*Ũ<Ã+ɂÌ%ŝƆʊͨǗƭǧ. 26.
(130) RWc*ɜžAɅ. ŀ(ʨ (ɾşAđ)*ȝƏDVWsFU+. 26 ʡdMUSFO}+ 27 ʡO}^sFU+ 87 ʡ(ªǗ>áɂ Ì* 1 ƄŝȨ% 3 ƄŝȨ+>>DVWsFU 16 ʡ% 10 ʡ dMUSFO} 16 ʡ% 11 ʡO}^sFU 56 ʡ% 31 ʡ%'. ɶ. ŝƆʊ*ĈƂ+ɚ6'. 3Àǩ«+Àǩ%ɕŷƀǁ$ɇƖ. ɂ*ŝAȚ#ƭǧAɅ. ŝȚŀ7Àǩ*ƅǃAáȨ%7Ȋ 180 ǣ. Ż3$Ɏġnj B. gibsoni ŒƐǤ*ɕŷ+ʧƝŨǩLJʬǠ'&*NjŅǫ 'ȸĴǤǍ%%7(ƈƕɄ*|FcNuTƐȽăŢƙƉ$* B. gibsoni *Ƀ§ǹ ɚ(:. #ǹę%Àǩ*ęȩ+ żųðȸĴǤǍ8ȸĴǣǔĖǫǞį. À.ǒ> !Ƶɳ B. gibsoni Ƀ§ɄƶăŢ$ƖÂ>ƀ% ɄƶƖƑ+Ȋ 1, 8, 29, 85 Żǭ
(131) :.ÀǩŻ(Ʌ. ƹęʠǭ+ RBC, PCV,. Hb, PLT
(132) :. CRP %ɂÌÇ(ÀǩŴ%*ÀǩŻAɝƑ3áȨ *Àǩ«(
(133) #ɇƖɂ*ŝƆʊ(
(134) =ÀǩǑAɝ0 áŝȨ(
(135) =ÀǩǑ+KFƖę[72]AǗ #ƅőīAɝƑáȨ* ÀǩŻŴ';.(Ȋ 1, 8, 29, 85 Żǭ
(136) :.(ÀǩŻ* RBC, PCV, Hb, PLT, CRP *ƅőī+ Krusukal Wallis Ɩę[72]AɅ ÃƎ0#*ȞɑɏƎ+ Microsoft Excel [mcGHDʮXLSTATʼAddinsoft, New York, USAʯAǗ # ɝƑ#
(137) <ƅőƩƻA 0.05 %. ʶʲȝƏ DVWsFUdMUSFO}O}^sFUŝŀ*ÀǩǑ+1 ƄŝȨ>> 63ʭʱ50ʭ25ʭ$<3 ƄŝȨ+>> 80ʭʱ 46ʭ16ʭ$. 1 ƄŝȨ3 ƄŝȨ>>(
(138) = 3 Ì*ÀǩǑ. *Ƨɬ$+Ȩ%7(O}^sFUȨ* 2 Ì:<ƅő(ÀǩǑ¦. . ɂÌ*ŝƆʊÇ(
(139) =Ƨɬ%# 3 ƄŝȨ% 1 ƄŝȨ$ÀǩǑAɝƑ ī+ɚ6;>'. ʮɆ 2 − 2ʯ. 27.
(140) áɂÌŝ(
(141) =ÀǩŻ*ıý³+ 1 ƄŝȨ>>46.1 ± 13.7 Ż 41.5 ± 11.5 Ż77.6 ± 28.7 Ż$. 3 ƄŝȨ+>> 85.0 ± 33.4 Ż. 77.8 Ż ± 25.2 Ż114.4 ± 16.5 Ż$. DVWsFUȨ%O}^sF. UȨ(+ 1 ƄȨ% 3 ƄȨ(
(142) =ÀǩŻ*ƅőīɚ6;>ʮɆ 2 − 3ʯ Ɇ 2 − 4 (+áȨ*Àǩ«(
(143) #ɇƖɂ*ŝƆʊ(
(144) =ÀǩǑAǺ1 ƄŝȨ$+DVWsFUȨ%dMUSFO}Ȩ+>> 10ʭ13ʭ ŝƆʊ(ÀǩO}^sFUȨ*Àǩ*âɑ 14 «+ŝƆʊ(+ Àǩ+4;>½« 1 Ƅʊ*ŝȚŀ(Àǩ3 ƄŝȨ$+ŝ Ɔʊ*ÀǩǑ+DVWsFUȨ 50 ʭdMUSFO}Ȩ 60 ʭ%ą ÏO}^sFUȨ+ 3 Ƅŝ(
(145) #7Àǩ«+ŝƆʊ¿(+4 ;>'. Ɇ 2 − 5 (+ 1 ƄŝȨɆ 2 − 6 (+ 3 ƄŝȨÇ*ɄƶƖ. ƑȝƏAǺ1 ƄŝȨ$+Ȋ 1 ǣŻ*dMUSFO}Ȩ%O}^sF UȨ*âɑ(
(146) # PLT (īɚ6;>3 ƄŝȨ$+dMUSFO} Ȩ%O}^sFUȨ(
(147) = RBC, Hb, PCV (īɚ6;>3dMUS FO}Ȩ*ÀǩȨȊ 8 ǣŻ( RBC, PCV *ıý³O}^sFUȨ(Ƨɬ #ƅő(ʫ 6;>'. '
(148) ô*Ɔʊ >*ɂÌŝ*°§(7ͨǗ+ɚ. . ʷʲȪġ ô*ǶȄ(Ǘ ɂÌ+DVWsFUdMUSFO}O}^sF U* 3 Ì$=>;*ɂÌ+ >7nj B. gibsoni ŒƐǤ(ƅÐ !ŻƉ $¼řàȯ$=[44]ƉǶȄ$+>;A¦ǗʅVteZǧƯ%ț4â@ #ÀǩǑ%ıýÀǩŻŴ3ŝƆʊ*ÀǩʏƞÐƏAɗ7*$= DVWsFU+sO|FdȖŞǕNJɤ$<ÚɃ(Ģ=¨Ǘƚĵ+ɏ ž># ' s|}D(Ģ=ƱŌAǺin vivo $+ B. gibsoni (ƅÐ% ># =[8, 43]DchR%*©Ǘ$nj B. gibsoni ŒƐǤ(Ǘ ;># =. 28.
(149) [8]¦ǗʅVteZǧƯ%*ț4â@ƭǧ(:=ÀǩʏƞÐƏ(! #+Ɩɒ >%' $ ǝʫ. ô*Ɩɒ$+DVWsFUȨ$+ÀǩǑ+ʶÌ*. ŝƆʊA 3 Ƅ(ĸʈ=%ıýÀǩŻŴ+ƅő(ĸʈ#.
(150) < ę*ɺĸÐƏ+=7**ÀǩǑ+ƸĥÀǩ«*ŝƆʊ*Àǩ Ǒ+ąÏ:. #DVWsFU*ÀǩʏƞÐƏ+ %Ŋ@>. dMUSFO}+ac|SFO}ȖâŖŞȿɂ$<I~}`jDǤ( ƱŌAǺ%Ǵ;># =[43]dMUSFO}+ B. canis (+ in vivo $ ƱŌAǺ[70]B. gibsoni (
(151) #+ in vitro $ŒÞŌ=in vivo $+ Øǎŝ$+ÐƏ' [7, 68]dMUSFO}+ĊÌ©ǗǧƯocR~( ț4ɯ3># =7**¦ǗʅVteZǧƯ(ț4â@ÀǩʏƞÐƏ+ ž$. ô*Ɩɒ$+dMUSFO}Ȩ+DVWsFUȨ:<Àǩ. Ǒ+ȾİƸĥ# =ʫŝƆʊAĸʈ#7ıýǩǤŻŴ(ī'À ǩǑ712Ĉ@;'. 3Àǩ«(
(152) =ŝƆʊ*ÀǩǑ+ ǝʫ. ƆʊAĸʈ#7DVWsFUȨãƘ(ŝƆʊ*ÀǩǑ+ąÏ: #dMUSFO}* 1 Ƅ*ŝ+ÐƏǫ$' %Ŋ@> ¦ǗʅVteZǧƯŀ(ț4â@=ɂÌ%#DVWsFU%dMU SFO}$+ÀǩʏƞÐƏ+ÕÃ$. ȸĴǒĂ$ ę*ÀǩʏƞÐƏ. (ƆĿ#ªǗ=Ăâ(+1 ƄA6&(ǵƆƭǧ(ʑęǫ$=%ɚɠ =ŇɊ=%Ŋ@> ĢDž$Ǘ O}^sFU+DVWsFUdMUSFO}(Ƨ0 =%ƅő(ÀǩǑ¦3 Ƅ(ŝƆʊAĸʈ=%ÀǩǑ+¦Ƹ#
(153) < ÀǩŜÉ8ɺĸÐƏ(ƅÐ$=%ž; %'. O}^sFU+D. VWsFU8dMUSFO}:<¦ǗʅVteZǧƯŀ*ț4â@(ƅ Ð'ÀǩʏƞɂÌ$=%Ȫ ;> ŝȨÇ*ɄƶƖƑAƹęáȨ*ţÂ(´<' %AɝƑdMU SFO}Ȩ$ŝË*¦ǗʅVteZǧƯ*Ȋ 1ʱ8 ǣŻ(O}^sF. 29.
(154) UȨ(Ģ#âɑ³8ÀǩȨ%*ʊ(ƅőīAɚ6=ʠǭ. ŝŀ+. īɋ;>ɢɄ8ɄĤƍƸĥǤ*ʄǤĶ8ôŃ*Ķâ ÀǩǑ(ĽʟAÜ 2%+'. :. #ɄƶƖƑ³ ;áȨ*ţÂ(+Àǩ(ĽʟAÜ2´. <' %ǹɚ$. 30.
(155) Ĥť Ȋ 1 ȑ$+nj B. gibsoni ŒƐǤ(
(156) #ė½Ō8ƅÐǑAǹɚ¦ǗʅVte ZǧƯAĚŹ 80 «(Àǩʏƞ*6(Ǘʅ¬ĕǫ(ŞÚɃ¨ǗAƅ= O}^sFUAȊ 29 ǣŻ3$ŝ#ÀǩʏƞÐƏAɗ*ȝƏ O}^sFUŝȨ*ÀǩǑ+ĢDžȨ%Ƨɬ#ƅő(ÀǩǑ¦ ǩƀ*ɢɄ+ĢDžȨ:<ɫĶ$ ¨Ǘ+ɚ6;>'. À. 3O}^sFUŝ(+ʄċ'Í. . Ȋ 2 ȑ$+nj B. gibsoni ŒƐǤ(
(157) =¦ǗʅVteZǧƯŀ(ț4â@= ɂÌ*ÀǩʏƞÐƏAƖɒ=6DVWsFU%dMUSFO}AO} ^sFU%Ƨɬ;(ŝƆʊ(:=ÀǩʏƞÐƏAɝƑDVW sFU$+ 1 ƄŝȨ*ÀǩǑ+ 3 Ì*$ ǝʫ. ŝƆʊA 3 Ƅ. (ĸʈ=%ıýÀǩŻŴ+ƅő(ĸʈ#
(158) < ę*ÀǩɺĸÐƏ+=7* *ÀǩǑ+ƸĥÀǩ«*ŝƆʊ*ÀǩǑ+ąÏdMUSFO} 7ÀǩǑ+ʫŝƆʊAĸʈ#712Ĉ@;ıýǩǤŻŴ7ī' 3Àǩ«*ŝƆʊ*ÀǩǑ+ 3 Ì*$ ǝʫ ŸO}^sF U+ 1 Ƅŝƀ*Ƨɬ$+* 2 Ì:<ƅő(ÀǩǑ¦ŜÉÐƏÕ Ã(ɚ6;>3ŝƆʊA 3 Ƅ(ĸʈ=%ÀǩǑ*¦Ƹ(ƅÐ$< Àǩ«7ŝƆʊ(+ÀǩŜÉ># :<¦ǗʅVteZǧƯŀ*O}^sFUŝ+nj B. gibsoni ŒƐ Ǥ*ÀǩŜÉ(ƅÐ$=%@. 3O}^sFU+ŞÚɃÐƏA. ƅ=DVWsFU8dMUSFO}(Ƨɬ#nj B. gibsoni ŒƐǤ*Àǩ ŜÉ(·>ŝƆʊAĸʈ>,:<ÐƏǫ$=%Ǻí>¦Ǘʅ VteZǧƯŀ*O}^sFU 3 Ƅŝ+nj B. gibsoni ŒƐǤ(ƅÐŌ ʫ ƭǧƯ%Ȫ ;>. 31.
(159) (%). ( g / dl ). ( x103 / µl ). PCV. Hb. PLT. ( x106 / µl ). (%). ( g / dl ). ( x103 / µl ). RBC. PCV. Hb. PLT. (%). ( g / dl ). ( x103 / µl ). PCV. Hb. PLT. . ( mg / dl ). ( x106 / µl ). RBC. CRP. ( mg / dl ). . CRP. ( mg / dl ). . ±. ±. 13.3. 4.4. ±. ±. ±. 234.3. 3.6. ±. ±. 12.6. 39.4. 5.7. ±. 204.1. NE. ±. 10.4. ±. ±. 45.8. 33.2. ±. ±. ±. 8.4. 24.8. 3.5. 80. 5.0. 17.8. 3.6. 9.6. 1.6. 150.1. 2.7. 7.1. 1.2. 5.2. 39.6. 2.7. 9.0. 1.5. . *. *. *. . 2.0. 269.2. 13.0. 41.2. 5.9. 214.0. 10.5. 33.6. 4.4. 13.0. 49.8. 8.4. 24.5. 3.4. ±. ±. ±. ±. ±. NE. ±. ±. ±. ±. ±. ±. ±. ±. ±. 67. 6-. 2.5. 168.5. 3.4. 8.4. 1.5. 157.1. 2.6. 6.9. 1.2. 5.1. 40.7. 3.6. 9.1. 1.5. **. **. **. **. **. . . 11.8. 56.8. 10.0. 30.5. 4.4. 153.1. 10.0. 31.4. 4.2. 14.7. 24.5. 8.6. 26.5. 3.9. ±. ±. ±. ±. ±. NE. ±. ±. ±. ±. ±. ±. ±. ±. ±. 13. -. 32. NE< %2 *<DC /
(160) */
(161) 4 $" 7 p < 0.058 **</-
(162) 6-
(163) 4 $" ( p < 0.05) #<DC /
(164) */-/ $" ( p < 0.05) <CRP ('5+720 mg/dl83 20 mg/dl
(165) . . .29 ,#. .8 ,#. ( x106 / µl ). RBC. .1 ,#. CRP. . N. . . 6.5. 10.8. 3.6. 10.4. 1.7. 98.0. 2.9. 7.6. 1.2. 5.5. 2.4. 2.9. 8.4. 1.5. . #. #. #. #. #. #. #. . 5.6. 219.7. 12.2. 35.6. 5.2. 170.9. 10.1. 32.6. 4.7. 13.4. 43.5. 8.4. 25.1. 3.8. ±. ±. ±. ±. ±. NE. ±. ±. ±. ±. ±. ±. ±. ±. ±. 142. 1. 7.0. 186.5. 8.8. 11.2. 1.8. 112.5. 2.7. 7.5. 1.3. 5.5. 28.0. 3.0. 8.9. 1.6. . . . 1.7. 290.0. 13.6. 39.9. 5.9. 162.9. 9.9. 31.9. 4.6. 13.4. 43.6. 8.1. 24.3. 3.8. ±. ±. ±. ±. ±. NE. ±. ±. ±. ±. ±. ±. ±. ±. ±. 100. 6-. */. DC /. 1. 8. 0: 9. . 1, ;, 29 ,# DC /
(166) */ RBC, PCV, Hb, PLT, CRP 7 ! ± &). 5.8. 39.5. 3.5. 10.0. 1.4. 140.4. 2.5. 7.5. 1.2. 4.8. 33.1. 2.9. 8.9. 1.5. **. **. **. **. **. . . 15.5. 42.1. 8.5. 25.3. 3.4. 190.3. 10.6. 34.1. 4.9. 13.2. 43.1. 9.2. 27.1. 4.2. ±. ±. ±. ±. ±. NE. ±. ±. ±. ±. ±. ±. ±. ±. ±. 42. -. 1.5. 174.7. 9.9. 8.5. 1.4. 98.0. 2.7. 7.4. 1.3. 5.7. 25.6. 3.0. 8.8. 1.6.
(167) E 2 – 2. #?H . A;/
(168) . . 2"
(169) = B. gibsoni 17@(B> M!52"C. N!52"C. O. I(B. (B. (%). O. I(B. (B. (%). . 16. 6. 10. J63K. 10. 2. 8. J80K. . 16. 8. 8. J50K. 11. 6. 5. J46K. . 56. 42. 14. J25K. 31. 26. 5. J16K. F8C. . & L. . 0.01L. 1 !52"C +D*
(170) (B>:G &. LL. 3 !52"C +D*
(171) (B>:G &. 33. 0.001LL.
(172) E 2 − 3. (B% #?H. A;/
(173) +D*2").,(B43. ( .,& ± 9<'-) F8C. O. M!52"C. . O. N!52"C. . . 16. 46.1. ±. 13.7 4. 10. 85.0 ± 33.4 4 *. . 16. 41.5. ±. 11.5 4. 11. 77.8 ± 25.2 4. . 56. 77.6. ±. 28.7 4. 31 114.4 ± 16.5 4 **. . * . $? M!52"C N!52"C 60-. ( p <0.01) **. . $? M!52"C N!52"C 60-. ( p <0.05). 34.
(174) ;)>Q*1H(S) X X W. 4N(S) 10 \ 14. &#'. !%'. %' #'. K3. X(<;)J. L 2 − 4. 1H. M?K;)>Q*1HD. 35. [. [. 13 0. \. 4N(S). 10. 1HDUTV. [. Y. Z. ;)>Q*1H(S). Y(<;)J. 0. 60. 50. 1HDUTV.
(175) 3.4. 8.4. 3.0. 11.2. 5.1. 5.8 ±. NE NE NE NE. NE. NE. NE. NE. (%). (g/dl). (x103/µl). PLT. CRP† (mg/dl). NE. 6.5. 4.1. 11.6. 2.2. 7.0. 8.3. ± 137.8. ±. NE. ±. 293.3. ±. ±. ±. Hb. RBC. 3.1. 162.3. 2.5. 7.1. 1.3. 5.5. 39.7. 1.8. 6.2. 1.0. ± 262.8. ±. ±. ±. ±. ±. ±. ±. PCV. (x106/µl). CRP† (mg/dl). ±. ±. 13.6. (x103/µl) 298.6. (g/dl). PLT. Hb. 35.8. 9.9. ±. 40.1. (%). 5.2. PCV. 1.7. ±. 5.6. (x106/µl). 6.1. RBC. 6.3. ±. 340.2. 4.7. 228.8. CRP† (mg/dl). ±. ±. 10.5. (x103/µl) 297.1. (g/dl). PLT. Hb. 26.8. 8.4. ±. 32.1. (%). PCV. 3.7. 12.4. ±. 4.4. 1.3. ±. 13.6. 6.1. 5.3. 59.7. (x106/µl). 37.6. RBC. ±. 16.7. ±. ±. ±. ±. ±. ±. ±. ±. ±. 10. 2.6. 7.6. 1.1. 6.2. 34.0. 3.7. 10.6. 1.5. 10.0. 30.9. 4.0. 16.4. 65.9. 6.8. 20.9. 2.8. ±. ±. ±. ±. 5.1. 6.9. 1.1. 5.6. 13.7. 41.8. 5.7. 5.5. 7.3. 30.9. 9.2. 28.8. 3.9. 0.4. ±. ±. ±. ±. ±. ±. 0.6. 23.0. 2.5. 8.4. 1.2. 0.5. 3.1. 302.6 ± 178.4 239.0. 15.3. 43.4. 6.0. 3.8. 271.2 ± 201.3 286.6. 11.8. 35.3. 4.8. 14.3. 39.2. 7.8. 23.1. 3.3. NE. NE. NE. NE. NE. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. 16. 5.8. 18.3. 2.4. 6.2. 138.3. 2.6. 6.7. 1.2. 5.2. 169.4. 2.6. 7.2. 1.1. 3.6. 36. 8. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. 3.6. NE. NE. NE. NE. NE. ±. 201.9 ±. 14.0. 42.3. 5.9. 7.2. 327.0 ±. 9.9. 31.4. 4.0. 16.8. 40.7 * 70.8. 2.7. 8.0. 1.2. *]!%'J%' #'J=:8 ( p < 0.05) ]CRP / C7@5RFU20 mg/dlVO64 20 mg/dl . . 29. 8. ±. 6.9. 46.9. (g/dl). (x103/µl). Hb. PLT. 9.7. 2.4. CRP† (mg/dl). ±. 20.7. (%). PCV. 1.4. 7.4. 108.1. 2.9. 7.4. 1.4. 6.3. 186.2. 1.7. 5.4. 0.7. 3.2. 17.8. 1.2. 3.8. 0.5. 6. ±. 16. 2.9. . (x106/µl). N. RBC. . 1. .
(176) . .
(177) . . . . 1 . 8. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. 7.1. 33.1. 7.7. 23.6. 3.2. 2.2. ±. ±. ±. ±. ±. ±. 281.4 ±. 13.3. 41.3. 5.5. 3.9. 246.3 ±. 10.1. 30.5. 4.0. 16.0. 61.1. 7.8. 23.5. 3.3. 10.4. 32.5. 4.4. 12.4. 34.3. 8.8. 26.3. 3.9. 14.8. 44.2. 6.5. 7.2. 0.4. 47.5. 3.3. 8.3. 1.4. 2.1. 2.6. 155.8 272.2. 2.1. 5.8. 0.9. 3.4. NE. NE. NE. NE. NE. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. 56 1.8. 5.1. 136.6. 2.7. 7.4. 1.3. 5.1. 127.5. 3.1. 8.2. 1.5. 5.8. 28.2. 3.8. 11.0.
(178) . 139.4 217.1. 3.3. 8.7. 1.5. 3.9. 54.3. 3.4. 9.9. 1.5. . *. . . ±. ±. ±. ±. ±. ±. ±. ±. 42. 3.6. 9.8. 1.7. 5.7. 30.8. 3.9. 11.1. 1.9. ±. ±. ±. ±. 3.6. 10.4. 1.7. 5.7. 2.8. NE. NE. NE. NE. NE. ±. 5.1. 263.9 ± 130.6. 14.9. 44.6. 6.7. 6.8. 200.0 ± 112.4. 10.6. 33.0. 4.6. 12.4. 35.4. 9.2. 27.6. 4.1. . . . L 2 5. ,EP$"'GB9I4
(179) AGE K32 RBC, PCV, Hb, PLT, CRPU 1 (<;)J V. 7.5. 46.1. 9.5. 29.7. 4.1. 0.1. 301.3. 14.4. 42.8. 6.1. 4.6. 268.6. 9.7. 30.7. 4.0. 12.3. 31.1. 7.6. 22.1. 3.3. 3.3. 9.5. 1.5. 2.4. 6.2. 1.1. 6.1. 1.7. 4.6. 0.9. 3.4. ±. ±. ±. ±. ±. ±. 0.6. 51.3. 1.5. 5.0. 0.7. 0.0. ± 165.4. ±. ±. ±. ±. ± 159.7. ±. ±. ±. ±. ± 177.4. ±. ±. ±. 14. .
(180) . N. ±. ±. 10.2. (g/dl). (x103/µl) 186.3. ±. ±. ±. 43.0. 14.0. (x103/µl) 244.4. CRP†. (x103/µl). PLT. (mg/dl). (g/dl). Hb. CRP†. (%). PCV. (mg/dl). (x106/µl). . . 59.2. (x103/µl) 222.3. RBC. CRP†. PLT. . 3.4. 13.8. Hb. NE. 9.3. 41.5. (%). (g/dl). PCV. (x106/µl). 1.8. 5.4. 128.3. 2.3. 6.4. 1.1. 5.4. 5.9. (mg/dl). (g/dl). Hb. PLT. (%). PCV. ±. ±. 5.9. 4.3. ±. 6.8. (mg/dl). (x106/µl). 152.1. . ±. 31.1. (%). 1.1. 3.9. 16.4. . NE. 270.0. 13.2. 39.5. 5.6. 0.7. 152.0. 11.9. 37.0. 4.9. 8.4. 162.5. 2.7. 9.9. 45.5. 8.9. . ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. . 0.0. 3.5. 10.5. 1.9. 0.0. 136.0. 0.9. 1.0. 0.8. 4.6. 139.5. 2.1. 6.5. 0.9. 2.1. 14.5. 4.6. 11.5. 1.8. 8. ± ± ± ± ±. 35.4 11.8 31.1 7.5. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. 5.2. NE. 198.5. 14.2. 42.5. 6.0. 6.2. 267.5. 14.6. 44.5. 6.2. 6.4. 192.3. 11.2. 33.0. 4.5. 17.8. 18.4. 8.6. 25.8. 3.7. 13.0. 38.9. 5.2. 16.1. 29.7. 9.9. 28.9. 4.2. 15.7. 46.4. 6.5. 4.6. 0.2. 0.2. . NE. 267.8. 16.3. 48.5. 7.0. 0.2. 237.5. 15.5. 46.2. 6.4. 5.0. 249.2. * 10.6. 6. . ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. . 124.4. 4.2. 9.5. 1.8. 0.2. 74.3. 1.1. 2.4. 0.4. 4.2. 152.5. 3.6. 8.7. 1.3. 5.6. 14.3. 3.9. 10.6. 1.8. . . 10.9. 30.4. 4.6. NE. 89.0. 14.1. 41.0. 6.3. 0.1. 209.8. 15.9. 46.6. 6.7. 4.0. 37. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. 5. 0.8. 29.7. 2.1. 5.8. 0.8. 3.0. 2.7. 7.0. 9.2. 0.0. 52.1. 1.3. 4.2. 0.6. 8.0. 52.1. 1.3. 4.2. 0.6. 2.0. 12.0. 2.3. 6.6. 1.1. . 209.8. 15.9. 46.6. 6.7. 18.6. 29.2. 10.8. 30.8. 4.6. 7.0. . 132.7. 4.0. 9.5. 1.7. 4.0. 13.6. * 32.5. *. 30.2. 9.1. 27.3. 3.9. 0.7 . ±. 66.6. 1.2. 3.3. 0.5. 6.2. 119.6. 3.9. 9.9. 1.7. 4.9. 13.3. 3.4. 9.1. 1.6. . 29.6 . NE. 223.1. 15.8. 46.6. 6.8. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. 11.
(181) . 30.2. 3.0. 8.2. 1.3. 59.6. 3.4. 8.5. 1.8. 5.8. 115.3 224.9. 2.2. 6.3. 1.0. 5.5. 154.5 231.3. 2.1. 7.2. 0.9. 2.3. 11.6. 2.2. 6.8. 1.0. . 3 . *]0-/ %' #'J!%'J=:8 ( p < 0.05) **]1HJ !%'J + 2 3=:8 ( p < 0.05) ]CRP / C7@5RFU20 mg/dlVO64 20 mg/dl . . ±. 4.2. RBC. CRP†. PLT. Hb. PCV. 85 RBC. . 6.7. 2.8. ±. 16.2. (mg/dl). (x106/µl). CRP†. 8 RBC. 29. 23.5. 8.0. ±. 23.8. (x103/µl). PLT. 2.8. 26.5. ±. 8.6. (%). (g/dl). Hb. 8.0. ±. 25.9. 3.7. 2. . ±. 1.2. 10. 3.7. . (x106/µl). PCV. 1 RBC. .
(182) . . **. **. . NE. 270.8. 15.6. 45.6. 7.0. 0.2. 341.1. 14.3. 43.0. 6.2. 9.0. 242.9. 9.0. 28.9. 3.7. 14.1. 34.8. 7.3. 22.2. 3.1. . ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. 31. 3.3. 9.5. 1.4. . 149.7. 3.8. 10.5. 1.8. 0.2. 150.3. 3.0. 8.9. 1.5. 6.8. 181.3. 2.9. 8.6. 1.3. 6.6. 32.8.
(183) . . *. *. *. . ±. ±. ±. ±. ±. ±. ±. ±. 26. ±. ±. ±. ±. . NE. 274.6. 16.1. 46.8. 7.2. 0.2. . ±. 346.1 ±. 14.5. 43.8. 6.3. 9.5. 235.7 ±. 9.1. 29.2. 3.7. 14.2. 36.1. 7.6. 23.3. 3.2. . 130.9. 3.8. 10.7. 1.8. 0.2. 134.2. 3.1. 9.2. 1.4. 7.4. 165.0. 2.8. 8.5. 1.3. 6.5. 32.0. 3.4. 9.8. 1.5. . . . . L 2 6. ,EP$"'GB9I4
(184) AGE K32 RBC, PCV, Hb, PLT, CRPU Y(<;)J V. 7.5. 22.2. 7.8. 23. 3.6. NE. 251.0. 13.0. 39.4. 5.8. 0.2. 315.0. 12.9. 38.6. 5.6. 4.1. 280.0. 8.6. 27.6. 3.7. 14.1. 28.2. 6.0. 16.8. 2.6. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. ±. 5. 1.3. 24.8. 2.8. 7.6. 1.6. 222.1. 2.4. 6.2. 1.4. 0.2. 213.4. 2.0. 5.8. 1.6. 2.6. 245.9. 3.0. 8.7. 1.2. 7.6. 35.8. 2.2. 5.2. 0.8. . . **. **. . .
(185) Šǁş ļ B. gibsoni òęŎĮƁ»':ļ( B. gibsoni pƷîòęĽī. 1ǀűƈ ĈĒ(ļ B. gibsoni òęŎ)ƅĈĒ>rë'×" :Ô¦ŕ)ĮƁ»( +$!# 9§8Å(Őń¿¯;" :[26, 46, 52]mąƿĒŎ' )pƷîòę :$5Ŗ8;9ļY]JAŎŐŎĥ& ŻÜn á&ļ (đĜƀİ85ƺòÞ& PCR Ĭ>Ņ Ɯ|ÇĝĚ'79¡ſĝ; " :[6, 14, 64] Š 1 ş7,Š 2 ş#)ļ B. gibsoni òęŎ(Īŏ7,ŐƤġ'! "ĝƊ ļ B. gibsoni òęŎ#)mÞ B. gibsoni 'òęļ)pƷîGceA' &:$ =;" :[10, 59]pƷîòęļ)Źźÿè6ŋöĽóo#ż8 Y]JAŎ>ŐŎ:eLH>Ď:#&[64, 34]Đòęļ'Ñ:òę eLH>Â:Ɔũ'&:(4ĮƁ»(ĿØ'$. ")»½( B.. gibsoni (pƷîòęĽī)ŻÜnƞƆ&ƣëuƲ# : ļ( B. gibsoni (pƷîòęĽī'! ");1#đĜƀ8( PCR '7 :¡ſĝ'79Ë;"[43, 64]. ?ļ B.gibsoni 'òę. :$ŪńòęĽó$&9ŻÜő')pƷîòę$«š$Ŵ 8;:[13]& =B. gibsoni òę( :ļ#)đĜƀ(¡ſƟ PCR (ĝƦŇyo(À ª#. "5B.gibsoni ~'Ħ. " :¨Ÿî>Ŵô:ìƆ :1. Ä6`OWtƤ&%(òę(eLH[@HNk6 B. gibsoni pƷîòęļ(ƀ İîĽ'¢0åƱ'! ")'ƇĊ;" & [43] #Ēŗŝ#)ļ B. gibsoni òęŎ(ĮƁ»# :Ô¦ŕ(mĺōƧ' "ŻÜn á&ļ( B. gibsoni pƷîòęĽī>ćçĥ>®4"ƏĚ 8'Ä6`OWtƤ B. gibsoni òę'%(7
(186) &åƱ>¢0Ƈė:$ $5'ƿŻÜn á& B. gibsoni òęļ$ưòęļ(ƀİîĽ>Ĩƙ. 2ǀēă7,ąĬ. 38.
(187) 2 – 1. SkN(£Ƭ ƏĚ)ԦఠÖ(mĺōƧ' "2013 Û 4 č 1 Ĉ8 6 č 30 Ĉ1# ( 3 ičƢļŧĽſ(òętƤž(ą>œő'ĔƧŻÜn á& 1 Ĥyn (ļ 500 Ƴ>у$ ŻÜn á $)¥ƌ 1 Ûy'ƞÆ&ƘîŌð '7:Īŏĥ&!¥ƌČ'mŽĽó(}o6¢,Ƙ~ĝĚ'ŊÙ>ř& $$Ëų&"(уļ(ƹ s'Ñ")Ēŗŝ(Ɩĉ>ƎĊ «ñ>é уļ#)îÛƻ²Ŝļ B. gibsoni òęŎćçĥ'! "ƌŏƋƠ >Řƍ:$$5'Ä(Ďĸ¢,`OWtƤ(ƵÞ'! "ƹ s8ŵ¤ 9>Ɓ. Ä)Í¢,żÉĂ»(2>Āģ:ļ>Ä& $. ;yÄ>Ä 9 $`OWtƤž)"[B\gWfƄƽ[ghT dCh\dLǂbeAfjKcZhěâ{ŚƽŁ.kehFkChIfXCaKc Zhěâ{Śƾƿĕvƾ>Ņ "ƴƝŷŒo'Á×`OWtƤ(ƵÞ'! ")Û 4 č8 11 č1#ħč`OWtƤ>Ɓ. ~>ÊtƤ ÷q. ĥ& : ) 4 č8 11 č(Ƣ'tƤ>ÌĆ&. Čď( :. ~>pÊtƤ $. 2 – 2. B. gibsoni (ĝ đĜƀ8(ſ~(ĝ)ľĹ8(ąĬ[24, 25]'79ÌĆуļ(đĜƀ )ø¸$" EDTA >Ņ "ý¤DNA ù1#20'ť2014 Û 4 č8 9 č' ÖƔ( DNA ùGQTƽQIAamp DNA mini kit, QIAGEN Ś UCRƾ>Ņ "đĜƀ8 DNA >ùPCR ĝĚ1#`CVL 20'È (è2014 Û 10 čyƥŜĻŊő PCR '79đĜƀņĔ DNA 8. B. gibsoni >ĝ. 2 – 3. ƀİĝĚ. 39.
(188) уļ 500 Ƴr&đĜƀİý¤# 407 Ƴ'! "ƀİĝĚ>ÌĆ ƀİĝĚ)żƀłƉŤğƽCelltac-ǂĈĒƯěâ{Śƿĕvƾ>Ņ " RBC, PCV, Hb ¢, PLT >Ť. 2 – 4. ŮƉŃ "(ŮƉƇė) Microsoft Excel M[TDEAƽXLSTAT; Addinsoft, New York, USAƾ>Ņ "ÌĆÛƻ¢,ƀİîĽ(Ú¼(Õ'! ") One-Way ANOVA[19]'79ĎñÕ>ĝËèŲ'79Õ :Àª')_h [EgkWƃĢ(`h^CQTWU ĝË[20]'79ÅƞĨƙ(x(Ʋœ (ĝË) Fisher (ĢŘŘŀĝË>Ņ "Ƈė>Ɓ. ĎñĩĴ) 5Ƽ$&. ²ŜƇė#) 10 Ƴyn®1;:²Ŝ[19](2'! "Ƈė>Ɓ. . 3ǀŭĘ ļŧĽſŎtƤ(4'ĔƧŻÜn á&ļ 500 Ƴ(
(189) 38 Ƴƽ7.8%ƾ PCR ĝĚ'79 B. gibsoni ƪî>řƽpƷîòęŲƾ (
(190) 21 Ƴļ. B. gibsoni òęŎćçĥ>Ď" PCR Ʃî( 462 Ƴ(
(191) ļ B. gibsoni ò ęŎćçĥ :~ 32 ƳƽPCR Ʃîjćçĥ 9Ųƾćçĥ(& ~ 430 ƳƽPCR Ʃîjćçĥ&Ųƾ#. ƽƂ 3 - 1ƾ;8 3 ŲƢ#î. Ûƻ²ŜÄ(Ďĸ>Ĩƙ$<ƽƂ 3 - 1ƾƭƫ¢,²Ŝ(ª'Ďñ Õ)ƍ48;&. mąPCR Ʃîjćçĥ&Ų(Ú¼Ûƻ 7.4 Ĥ) B.. gibsoni pƷîòęļ(Ú¼Ûƻ 9.2 Ĥ$PCR Ʃîjćçĥ 9Ų(Ú¼Ûƻ 10.6 Ĥ79Ďñ'}. ƽ;; p <0.01, p <0.01ƾpƷîòęŲPCR Ʃîj. ćçĥ 9Ų¢, PCR Ʃîjćçĥ&Ų' ";; 37 Ƴƽ97.4%ƾ 26 Ƴƽ81.3%ƾ¢, 259 Ƴƽ60.2%ƾÄ 9$µŢpƷîòęŲ¢, PCR Ʃîjćçĥ 9Ų#)PCR Ʃîćçĥ&Ų'Ĩ."Ä:~(ª Ďñ'ƺ. (;; p <0.01, p <0.01). B.gibsoni òęŎćçĥ& 447 Ƴ(
(192) Ä 9$µŢ 275 Ƴ'!. 40.
(193) "PCR ƪîŲƽ16 Ƴƾ$ƩîŲƽ259 Ƴƾ'Ƹ©Ų':`OWt ƤÌĆĽī>Ĩƙ$<PCR ƪîŲ' "Ê&`OWtƤÌĆ; (p <0.01). " ļ(ª) 6.3%#PCR ƩîŲ( 44.8 %'Ĩ."Ďñ'} ƽƂ 3 - 2ƾ Ġ'ƀİĝĚ(ÌƨŸ#. 407 Ƴ(
(194) B. gibsoni pƷîòęŲ 36. Ƴ$ PCR Ʃîjćçĥ 9Ų 32 Ƴ¢, PCR Ʃîjćçĥ&Ų 339 Ƴ(ƀİ îĽ>Ĩƙ$<pƷîòęŲ( RBC, PCV, Hb ¢, PLT ) ;5 PCR Ʃîjćçĥ&Ų'Ĩ."Ďñ'}>ř(;; p <0.01, p <0.01, p <0.01, p <0.05)ƽƂ 3 - 3ƾ1pƷîòęŲ$ PCR Ʃîjćçĥ 9Ų>Ĩƙ $<RBC $ PCV 'Õ)28;&. Hb $ PLT )pƷîòęŲ#. Ďñ'}>ř(;; p <0.01, p <0.05)8'PCR Ʃîļ'! "ć çĥ(Ďĸ'79Ĩƙ$<ćçĥ 9Ų( RBC, PCV, Hb )ćçĥ&Ų 'Ĩƙ"Ďñ'}>ř(;; p <0.05, p <0.05) (Ƃ 3 - 3). 4ǀŴÐ wµ(ƏĚ)ļ B. gibsoni òęŎĮƁ»# :ԦఠÖ' "B. gibsoni pƷîòęĽī>ƏĚ5(# :ƏĚу(ĺōƧ#)ļ B. gibsoni ò ęŎ(ÛƢƌŏƳā) 25.4 Ƴ# 9 ¹Ú¼ 0.537 Ƴ( 47 $&. " : [26]. wµ(ƏĚŭĘ8ԦఠÖ(mĺōƧ'[BdeAtƤ(4ĔƧ ŻÜn á&ļ( 7.6% B. gibsoni 'pƷîòę" $ř;« ļ B. gibsoni òęŎĮƁ»# :ßŕĭĒÖ' "ÌĆ;«Ğ( PCR Ĭ>Ņ ƏĚ$Ĩ.:$ĭĒÖ( B. gibsoni pƷîòęŀ) 1.9Ƽ# 9 [64]° Ö(pƷîòęŀ(ąƺ»½Õ :$Ċ8$&. ». ½Õ(¡¶$")`OW( B. gibsoni Ďŀ6ńïÏÞ(ƛ ƣq:$ Ŵ 8;:wµ(ƏĚ#)pĊ#. pƷîòęļ#)ŋö(. Ņ6Źźÿ&%ijî'ŎĽƷî:$ :$>Ŵô:$[43, 64]ļ B. gibsoni òęŎĮƁ»(ŻÜĿØ)ŻÜn á&ļ(r' B. gibsoni. 41.
(195) pƷîòęŔã&ª#Ⱥ:$'ʼnñ:.$í=; wµĝĚ'Ņ PCR (òÞ)đĜƀ 1 l 9 10 (òęƕƀł>ĝ# :[24, 25]!19òęƕƀłā 10 / lĐIJ# ;*ĝ#& Ũ# :. B. gibsoni òęļ)ŪńòęĽóůŰ:$Ŵ 8;"9[13]PCR ƩîŭĘ )ì5òę>Ë:5(#)& (4Ēŗŝ#) B. gibsoni òęŎ (pƷîòę>õþ:4'PCR ' "ćçĥ5ŴôPCR Ʃîjćç ĥ( :Ų>pƷîòęŲ$(Ų$"ĝƊ>Ɓ òę. B. gibsoni. "5ŻÜŎĽ(ŐŁ&ćçĥ&$Ą;~#đĜƀ. ( B. gibsoni PCR ĝòÞyo(Àª5 9
(196) :4PCR Ʃî#ćçĥ& Ų(r'5òęļȺ:¨ŸîÊ')Ë#& ;8(´ƶķ> Ƈį:4(ąĬ$"ø~ĝĚŴ 8;:B. gibsoni òęè'ĝ;: ø B. gibsoni ø~)òę>
(197) ļGceA$&. "¡ſĵz:$(. ø¡Ķ'79ơďƢûŰ:$;" :[15,17,63]wèpƷîòę(Ą ')PCR $ćçĥ(2&8ø~ĝĚ5ū2ª=ąĬ>Ŵô:$#7 9ŦÞÂ$í=;. B. gibsoni òęĽī'ƭƫ¢,²Ŝ'7:åƱ)28;& pƷîòę ļ¢, PCR Ʃî#ćçĥ( :ļ(Ú¼Ûƻ)ƺ ¬'. mÞòę. B. gibsoni )ń~8Ê'üƨ;'ĵzòęŰ$ =;"9[10, 59]ļ B. gibsoni òęŎĮƁ»#)ơń>:/%`OWÎń'7: B. gibsoni òęğ{Â:4$í=; 1B. gibsoni pƷîòęļŲ#)PCR Ʃîjćçĥ 9Ų$ PCR Ʃîj ćçĥ&Ų'Ĩ."Ä:ļ(ªĎñ'ƺ. ļ B. gibsoni òęŎ(. s&òęŬƗ)[NTIP`OW&%(`OW±# 9[7, 11]Ä:ļ#) `OW'±;:ğ{ƺ1:$¡¶$Ŵ 8;& Ä& (ļ '5 B.gibsoni òęƍ48;" :;)Ä& $µŢ;Àª# 5żÉĂ»(à6ň#(`OW±eLHÊ')üƨ;& $>ř³ :$Ŵ 8;. 42.
関連したドキュメント
学生部と保健管理センターは,1月13日に,医療技術短 期大学部 (鶴間) で本年も,エイズとその感染予防に関す
参考 日本環境感染学会:医療機関における新型コロナウイルス感染症への対応ガイド 第 2 版改訂版
〇新 新型 型コ コロ ロナ ナウ ウイ イル ルス ス感 感染 染症 症の の流 流行 行が が結 結核 核診 診療 療に に与 与え える る影 影響 響に
Using the concept of a mixed g-monotone mapping, we prove some coupled coincidence and coupled common fixed point theorems for nonlinear contractive mappings in partially
Zhao, “Haar wavelet operational matrix of fractional order integration and its applications in solving the fractional order differential equations,” Applied Mathematics and
Also, extended F-expansion method showed that soliton solutions and triangular periodic solutions can be established as the limits of Jacobi doubly periodic wave solutions.. When m →
Intra-host models of malaria infection describe the dynamics of the blood stages of the parasite and their interaction with host cells which are RBCs and immune effectors [32].. One
大曲 貴夫 国立国際医療研究センター病院 早川 佳代子 国立国際医療研究センター病院 松永 展明 国立国際医療研究センター病院 伊藤 雄介